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The 3 weeks pre-partum to 3 weeks post-partum is a challenging time for dairy cows 
because of both environmental and biological changes taking place in preparation for parturition 
and lactation.  At the animal level, excessive negative energy balance (NEB) can increase the 
risk of developing displaced abomasa, clinical ketosis, metritis, and/or retained placenta and can 
negatively affect reproduction and milk production.  Non-esterified fatty acids (NEFA) and beta-
hydroxybutyrate (BHBA) are measurable blood metabolites used to estimate the level of NEB.  
The objectives of herein were to: 1) identify  critical  concentrations of NEFA and BHBA above 
which the development of diseases were more likely; 2) describe statistical methods for best 
evaluating these effects as risk ratios; 3) identify the NEFA and BHBA critical  concentrations  
associated with decreased reproductive performance and milk production; 4) evaluate the herd 
alarm level, i.e., the association between the proportion of animals sampled that had NEFA and 
BHBA concentrations above the thresholds and herd-level disease incidence, reproductive, and 
milk production outcomes; 5) compare the results of pooling samples versus evaluating 
individual animals that were above a herd alarm level; and 6) evaluate the herd-level sensitivity, 
specificity, and herd predictive value positive and negative when using individual samples to 
estimate herd-level risk.  Animals with elevated concentrations of pre- and post-partum NEFA 
(0.3 and 0.7 mEq/L, respectively) and post-partum BHBA (12 mg/dL) were more likely to 
develop diseases; less likely to get pregnant.  The effects of elevated metabolites on milk 
production at the individual animal level were different between cows and heifers, cows 
produced less milk while heifers produced more.  However, when animals were evaluated at the 
herd level (i.e., when more than 15-20% of the animals sampled had metabolite concentrations 
above the critical thresholds) elevated NEFA and BHBA were associated with decreased milk in 
all groups.  When evaluating NEB at the herd-level, pooled samples are not recommended 
because they have low sensitivity.  It is recommended to sample 15 animals to maximize HPV- 
and 20 to maximize HPV+.   The information acquired from this research will help improve 
transition cow monitoring and management strategies.   
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CHAPTER ONE  
INTRODUCTION AND LITERATURE REVIEW 
INTRODUCTION  
The following chapters of this dissertation will discuss: the objective thresholds of 
markers of excessive negative energy balance (NEB) during the transition period, and their 
association with negative downstream outcomes at both the individual animal and herd-level; a 
method to estimate risk ratios to evaluate this association when applicable; and the consequences 
of varying test sensitivity and specificity on herd-level parameters such as herd predictive value 
positive and negative.  The outcomes of interest were disease development (displaced abomasa, 
clinical ketosis, metritis and/or retained placenta); mature milk equivalent 305 (ME 305) based 
on 4 test days; and reproduction.  The metabolites, non-esterified fatty acids (NEFA) and beta-
hydroxybutyrate (BHBA) have been associated with NEB and the relative ease of measurement 
has made them useful for evaluation of NEB during the transition period.  The following 
literature review will describe the physiological background and contemporary information 
which was the basis for the development of the current study objectives.    
Define the transition period  
In response to lactogenesis, within a few days post-partum the demands for glucose, 
amino acids, and fatty acids are several fold higher (2.7, 2.0, and 4.5 times respectively) what 
they are pre-partum (Bell, 1995).  Although the concept of homeorhesis (Bauman and Currie, 
1980) has been a good foundation for understanding the coordination of the events necessary to 
meet the energy demands early in lactation, these events are complex and dynamic.  To 
complicate matters, a decrease in dry matter intake (DMI) starting pre-partum (Hayirli et al., 
20 
 
2002) limits the availability of the substrates, however it is important to note that even when 
DMI is forcibly maintained in the pre-partum period, some of the energy management 
mechanisms still take effect, i.e., fat is still mobilized thus NEFA is still elevated around 
parturition (Bertics et al., 1992 ).  
The time period in which these mechanisms unfold is routinely referred to as the 
transition period, which is generally confined to 3 weeks pre-partum to 3 weeks post-partum 
(Grummer, 1995; Drackley, 1999).  Although research on the changes that take place during the 
transition period and their association to downstream outcomes can be traced back to 1980s 
(Herdt et al., 1981b), the association between energy, the transition period and negative 
downstream outcomes was still difficult to evaluate.  For example, Herdt et al., (1981) 
recommended sampling BHBA in at least 7 animals to identify whether a herd was at increased 
risk of developing subclinical ketosis  (SCK); however, this research group also reported that 
neither BHB nor glucose could be used as valid indicators of energy balance (Herdt et al., 
1981a). 
It was not until the 1990s that significant progress on this topic was made at both the 
nutritional and metabolic level (Bell, 1995; Grant and Albright, 1995; Grummer, 1995; Goff and 
Horst, 1997; Drackley, 1999).  This lag in research of the transition period may be due to the fact 
that this period is a very dynamic time period for a cow, most diseases are likely to occur early in 
lactation (Ingvartsen et al., 2003), and thus the potential variability between animals and herds 
has been difficult to study (Drackley, 1999).   To illustrate the complexity in interpreting 
information from research during this time period, take for example the contradiction in results 
between studies that demonstrated that high energy diets (from fat or other sources) in the dry 
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period were beneficial (McNamara et al., 2003; Douglas et al., 2004) versus more current 
research which contradicts these findings (Douglas et al., 2006; Janovick et al., 2011).  
Although this review will not focus on the details of management, environmental 
considerations, nutrition, or genetics these are all important factors which can affect the 
transition period and can be associated with a successful lactation.  Dairy cows under current 
management conditions routinely undergo several pen moves during the transition period and 
these non-dietary factors can negatively affect performance and health during the transition 
period (Contreras and Overton 2004).   More recent research has looked at stress, measuring 
cortisol effects in the blood and feces, and inflammation, measuring acute phase proteins such as 
haptoglobin (Huzzey et al., 2011) as risk factors of the development of negative downstream 
outcomes.  Although Huzzey et al., (2011) reported that NEFA was a better predictor of the odds 
of developing disease, cows still experience stress and inflammation during the transition period 
(Bossaert et al., 2011) and stress can increase NEFA concentrations (Leroy et al., 2011).   
Although this is a very brief description of factors to consider during the transition 
period, they play a very important role especially as cow rations are better formulated to meet the 
energy needs of dairy cows.  In fact, recent research which evaluated milk production in 47 herds 
receiving the same diet suggests that over 50% of the observed variation in milk yield across 
dairy farms is not related to nutrition but rather to management or environmental factors (Bach et 
al., 2008). 
In addition to the environment, genetic factors may also play a role in a cow’s ability to 
transition well.  Research specifically evaluating the heritability of the levels of NEFA and 
BHBA in transition dairy cows has been reviewed in a herd in Greece (Oikonomou et al., 2008).  
Although this research suggests that there may be some heritability in the levels of NEFA and 
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BHBA produced by the cow, this research was performed on only one herd.  In order to improve 
the external validity of this study, the same genetic model was used to evaluate 100 herds in the 
northeast (USA) and found no significant heritability associated with NEFA and BHBA levels 
(Ospina et al., not published).  However, in these 100 herds, the ratio of sire to daughters was 
low (889 sires with 2728 daughters) and this low ratio may have interfered with the ability to 
find the genetic association if present.     
Lastly, it is important to note that although the transition period has been generally 
confined to 3 weeks pre- and post-partum, the entire dry period should be considered a period of 
transition because it can affect the cow’s ability to go through the transition period sometimes 
even more so than the events that take place directly before parturition.  For example, when 
evaluating energy in diets during the far-off (> 25 d pre-partum) versus close-up (< 25 d pre-
partum) period, Dann et al., (2006) reported that overfeeding during the far-off period had a 
greater negative impact early in the transition period due to DMI, and consequently increased 
levels of NEFA and BHBA. 
Negative energy balance  
According to the National Animal Health Monitoring System (NAHMS), in the 1940s 
there were about 25 million cows (USDA, 2007) producing about 2,000 kilograms of milk per 
year (Capper et al., 2009) and approximately 130 million people (U.S. Census Bureau, 2012a). 
Currently there are about 9 million cows providing approximately 9,000 kilograms of milk per 
year and feeding approximately 300 million people (U.S. Census Bureau, 2012a; U.S. Census 
Bureau, 2012b).  Although this improvement in the efficiency of milk production is based on 
several factors such as management, nutrition, and genetic selection, the cow’s ability to achieve 
this production is innate and arguably based on the concept of homeorhesis, i.e., the cow’s ability 
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to coordinate the metabolism between several body tissues in order to partition nutrients to 
support the dominant physiological process like pregnancy or lactation  (Bauman and Currie, 
1980).  
Early in lactation, the demand for glucose to support lactogenesis cannot be fulfilled by 
dietary intake; therefore, dairy cows will enter a state of NEB (Bell, 1995; Grummer, 1995; 
Overton et al., 1998; Ingvartsen and Andersen, 2000).  Fortunately, there are several energy 
management mechanisms in place at parturition which help to enhance gluconeogenesis from 
non-carbohydrate precursors and spare glucose utilization (Bell, 1995) to provide the cow the 
ability to meet the energy demands of lactogenesis.  In addition, ketones and NEFA can be 
utilized for milk fat synthesis (Palmquist et al., 1969).  Therefore, with these mechanisms in 
place, it is normal for a cow to have some level of circulating NEFA and BHBA early in 
lactation; however, there is a critical point above which detrimental outcomes are more likely 
and signify an excess of negative energy.  The following is a general review of the energy 
mechanisms in place to help meet the demands of lactogenesis through gluconeogenesis, 
lipolysis, and ketogenesis and explain how NEFA and BHBA can be used as markers of NEB. 
Metabolic hormones in the transition period 
Increased concentrations of NEFA and BHBA in the periparturient period are in part due 
to hormone-activated cues in place to help the cow meet the energy demands of lactogenesis.  
The following is a general review of the hormones involved (e.g., glucagon, insulin, 
catecholamines, glucorticoids, estradiol, leptin, and somatotropin) during the periparturient 
period and their effect on energy mechanisms. 
When a cow enters NEB, glucagon is released by the pancreas and promotes 
gluconeogenesis in the liver by increasing extraction of amino acids from the blood for 
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conversion to glucose (Brockman et al., 1975).  Glucagon infusions have been shown to promote 
liver glycogenolysis, enhance gluconeogenesis, while not increasing lipolysis from adipose tissue 
in early lactation (She et al., 1999).      
Insulin, which is also released by the pancreas, promotes glucose and ketone utilization, 
lipogenesis, and opposes lipolysis in insulin sensitive tissues like adipose tissue and skeletal 
muscle.  In the liver, insulin decreases beta-oxidation capacity (Jesse et al., 1986) and increases 
triglyceride synthesis (Cadorniga-Valino et al., 1997).  During the transition period, a cow 
undergoes a state of insulin resistance (Bell, 1995).  Insulin resistance allows the body to react 
differently even when insulin is elevated, thus lipolysis persists even when insulin is elevated 
(Vernon and Taylor, 1988) which occurs when there is increased glucose concentration in 
circulation.   
Although the exact mechanism of insulin resistance in adipose tissue is still under 
investigation, Lemor et al., (2009) reported that there was decreasing adiponectin sensitivity in 
adipose tissue after calving and this may contribute to insulin resistance by adipose tissue.  
Sundvold et al., (1997) reported that insulin resistance is likely mediated through the actions of 
peroxisome proliferator-activated receptor-gamma (PPAR-gamma) on adipose tissues.  The 
activation of PPAR-gamma, enhances insulin action and decreases the release of fatty acids from 
adipose tissue (Guo and Tabrizchi, 2006).  Thiazolindinediones (TZD) are the most potent 
ligands of PPAR-gamma (Houseknecht et al., 2002) and given that it enhances insulin action, it 
may be utilized to reduce lipolysis.  Smith et al., (2009) evaluated the effect of 2,4-
thiazolidinedione (TZD) a potent synthetic ligand for PPAR-gamma and found that TZD 
administration pre-partum improved metabolic health and DMI in periparturient cows and may 
decrease dependency on body fat reserves.  While studying the effects of high versus low energy 
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diets in the dry period and the association with TZD on insulin responses, Schoenberg et al. 
(2011), found that although there was no change in insulin concentrations based on TZD treated, 
cows treated with TZD tended to be more sensitive to insulin based on an insulin challenge.  One 
of the challenges associated with TZD is that it must be administered via injection and this is 
impractical in most dairy settings, however, the mechanisms by which this drug works may help 
develop the understanding of insulin resistance and may lead to better management or other 
treatment options.   
During the transition period, cows can undergo a lot of stress due to diet changes and pen 
moves.  There are several physiological adaptations to stress.  Within minutes after a stressful 
event, there will a rise in catecholamines (e.g., epinephrine and norepinephrine) produced by the 
adrenal gland.  This will increase cardiovascular output, activate the immune system, and 
increase mobilization of energy reserves, i.e., increase NEFA levels (Sapolsky et al., 2000).  In 
the periparturient dairy cow, there are substantial increases in number of beta-receptors on 
bovine adipocytes during early lactation compared to a dry cow which makes the peri-parturient 
cow more responsive to the effects of catecholamines (Jaster and Wegner, 1981).  This is 
important because the enhanced response to stress hormones early in lactation can exacerbate the 
NEB status of the animal by increasing the amount of circulating NEFA concentrations.  
Glucocorticoid (e.g., cortisol) concentrations will also increase in response to stress.  In 
the weeks leading to parturition, cortisol concentrations increase, however, approximately 2 days 
prior to parturition, the cortisol concentrations increase exponentially (Patel et al., 1996).  
Initially, the effect of cortisol is to accentuate the actions of catecholamines (Reynaert et al., 
1976), however the long term effects of elevated levels of glucocorticoids can decrease over all 
health due to immunosuppression (Munck et al., 1984), reduced feed intake (Tempel and 
26 
 
Leibowitz, 1994), and compromised reproductive performance (Johnson et al., 1992).  The 
secretion of cortisol is episodic and subject to individual variation (Thun et al., 1981).  Also 
sampled collection may increase levels, making monitoring cortisol difficult.  Huzzey et al., 
(2011), explored the association between fecal and blood cortisol, along with other hormonal and 
energy-related predictors, and disease.  Although this study concluded that NEFA, a marker of 
NEB, was a better predictor of disease outcomes than cortisol, increased cortisol levels can have 
a negative impact on reproduction and milk production.   
 Estradiol concentrations rise throughout pregnancy and peak 1-2 weeks before term (Bell, 
1995), this is an important event because it has been implicated in the inappetance of ruminants 
during late pregnancy (Sechen et al., 1988).  However, the direct effects of estradiol on specific 
tissues have not been established (Grummer et al., 1990), and more recent research has 
demonstrated that estradiol treatment is not associated with lipolysis or hepatic fatty acid 
metabolism (Bremmer et al., 1999).     
Leptin is synthesized by white adipose tissue and is negatively regulated by 
undernutrition, i.e., to signal the need for food consumption (e.g. increase appetite) leptin levels 
are low, and to signal satiety leptin levels rise.  Systemic administration of leptin is associated 
with reduced feed intake and increased energy expidentrue (Ahima and Flier, 2000).  During the 
transition period, at a time when there is a decrease in nutrients, decrease in insulin and an 
increase in growth hormone concentration, there is also a decrease in leptin concentration (Block 
et al., 2001; Block et al., 2003).  Although the leptin control mechanisms are still under 
investigation, Thorn et al., (2008) demonstrated that hypoinsulinemia is partly responsible for the 
decrease of leptin concentrations, and that hyperinsulinemia was associated with an increase in 
leptin concentration.     
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 Early in the post-partum period, plasma concentrations of somatotropin rise and have a 
natural increase at parturition and this is the primary homeorhetic regulator during the transition 
from pregnancy to lactation (Bell, 1995).  By opposing tissue response to insulin, somatropin 
also decreases rates of lipogenesis (Bauman and Vernon, 1993) and helps partition glucose for 
mammary use.  Additionally, differences in growth hormone receptors in the liver compared to 
skeletal muscle suggests a role of somatotropin in regulating tissue-specific changes in 
responsiveness during the transition period (Wook Kim et al., 2004). 
Gluconeogenesis in the transition period  
Glucose management in ruminants is of particular importance because ingested 
carbohydrates are routinely fermented to short-chain fatty acids by rumen microbes; therefore 
glucose must be synthesized by the liver (Reynolds et al., 1988).  The three most abundant fatty 
acids are: propionate, butyrate, and acetate; however of these three, only propionate can be used 
as a precursor for the synthesis of glucose with valerate and isobutyrate also available, but used 
significantly less (Bergman, 1990; Reynolds et al., 2003).   It is important to note that insulin 
does not inhibit hepatic gluconeogenesis from propionate (Donkin and Armentano, 1995) and 
excessive amounts of propionate can lead to propionic aciduria which can have negative 
consequences on health (Allen et al., 2005; Deodato et al., 2006).  Rather, hepatic 
gluconeogenesis from propionate is regulated through the supply of glucose precursors, enzyme 
activity, and end-product feedback.  The ability to control the supply of glucose precursors will 
be discussed in a later section, under the use of ionophores.    
The factors associated with propionate gluconeogenesis will be discussed and an 
illustration of the control points for glucogenic precursor entry into gluconeogenesis the bovine 
liver is found in Figure 1.  A review by Aschenbach et al., (2010) reported that propionate is 
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converted through mitochondrial propionyl-CoA carboxylase (PCoAC), methylmalonyl-CoA 
mutase (MCM), and part of the tricarboxylic acid (TCA) cycle to oxaloacetate (OAA).  Once 
OAA has been created it is metabolized by phophoenolpyruvate carboxykinase (PEPCK) to 
phosphoenolpyruvate (PEP), and then to glucose or it can serve as an acetyl-CoA acceptor in the 
TCA cycle.  Because PCoAC, MCM, and PEPCK-M are necessary for propionate entry into 
gluconeogenesis, it seems likely that these may be control points in gluconeogenesis from 
propionate.  Although not much is currently known about the transcriptional or translational 
regulation of MCM and PCoAC in bovines, the enzyme MCM is dependent on vitamin B12 and 
peripartal administration of vitamin B12 can have positive effects on the metabolic status of high 
yielding dairy cows (Rollin et al., 2010).  Additionally, increasing propionate availability by 
feeding ionophores pre-partum induces hepatic PEPCK-C mRNA expression.  It is also 
important to note that pyruvate carboxylase (PC), an enzyme used for amino acid entry into 
gluconeogenesis, is elevated during feed restriction while PEPCK is elevated with bovine 
somatotropin (bST) treatment (Velez and Donkin, 2004; Velez and Donkin, 2005).  This is an 
important adaptation, because pyruvate (created with PC) can be used to maintain OAA 
availability to support hepatic gluconeogenesis.    
After parturition, there is a decrease in insulin and less is stimulated from the pancreas 
(Drackley et al., 2001).  A decrease in insulin concentration results in glucose sparing, due to 
decreased glucose utilization by insulin sensitive organs, and this allows the mammary gland to 
have additional access to glucose for lactogenesis (Komatsu et al., 2005).  Gluconeogenesis is 
closely linked to lactogenesis because the amount of glucose available for lactogenesis will 
determine the amount of milk produced (Mepham, 1993).   In addition to dictating milk 
production, glucose is a fundamental nutrient required by the brain and other tissues to function 
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and changes are not tolerated without adverse effects on the health of the animal, therefore it is 
under tight homeostatic control and concentrations will usually remain within normal 
physiologic levels.     
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Figure 1.1. Control points for glucogenic precursor entry into gluconeogenesis in bovine liver. 
The relative entry rates of propionate, lactate, and alanine can be regulated via differential 
expression of pyruvate carboxylase (PC), propionyl-CoA carboxylase (PCoAC), and the 
cytosolic and mitochondrial isoforms of phosphoenolpyruvate carboxykinase (PEPCK-C and 
PEPCK-M).  Abbreviations: AcCoA, acetyl CoA; ALA, alanine; GLU, glucose; GLY, glycerol; 
LAC, lactate; OAA, oxalaoacetate; PEP, phosphoenolpyruvate; PROP, propionate; PROPCoA, 
propionyl CoA; PYR, pyruvate; TCA, tricarboxylic acid cycle; TRiP, triose phosphates .  
(Recreated from Figure 2 in Aschenbach et al., 2010) 
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Lipolysis 
NEFA and NEB  
The excess energy stored in adipose tissue can be used during times of NEB by 
mobilizing fat in the form of NEFA.  In response to NEB, adipose tissue will be catabolized, 
therefore NEFA concentration will increase (McNamara, 1991), and some ruminants will start to 
mobilize NEFA pre-partum (Bertics et al., 1992).   In contrast to ewes that were starved for 3 
days, where the NEFA uptake and ketone output were relatively well matched; in the lactating 
animal the NEFA uptake and ketone production are no longer matched (Drackley and Andersen, 
2006).   This mis-match maybe related to the combination of increased growth hormone, 
decreased insulin, and decreased insulin to glucagon ratio which favors lipolysis.  Elevated 
NEFA levels can be achieved by four mechanisms: suppression of de novo synthesis or uptake 
and then esterification of fatty acids; promotion of lipolysis; reduction of intracellular re-
esterification of fatty acids released by lipolysis or a combination of all three (Bell, 1995).   
The liver receives approximately one third of cardiac output and removes approximately 
15 to 20% of the NEFA in circulation (Huntington et al., 1990; Drackley and Andersen, 2006).  
Once inside the liver, fatty acids have four pathways they can follow: complete oxidation in the 
TCA pathway to produce ATP; transported out of the liver in very low density lipoproteins 
(VLDL); used in beta-oxidation pathway to produce ketones or converted to ketones through 
peroxisomal oxidation; or stored in the liver as triglycerides (TAG; Drackley and Andersen, 
2006).  This review will focus on the effects of fat accumulation in the liver (hepatic lipidosis) 
and ketone production.   
The ruminant liver has a very low capacity for exporting VLDL.  There are 3 main 
proteins Apolipotrotein B100 (ApoB100), Apolipoprotein E (ApoE), and microsomal triglyceride 
protiein (MTP) involved in the regulation of synthesis and secretion of VLDL.  Although the 
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mechanisms by which these proteins are regulated have not been established, research has shown 
that ApoB100 is down regulated and the other two proteins are upregulated (Bernabucci et al., 
2004).  The down regulation of ApoB100 may be consistent with decreased synthesis and 
secretion of VLDL (Bernabucci et al., 2004) therefore TAG tend to accumulate in the liver 
(Herdt et al., 1983).  Excessive accumulation of TAG in the liver impairs normal function 
(Rukkwamsuk et al., 1999; Jorritsma et al., 2001; Murondoti et al., 2004) such as decreased 
insulin clearance (Strang et al., 1998b) and decreased urea production, which may also indirectly 
decrease the rate of gluconeogenesis (Strang et al., 1998a).   More recent research has evaluated 
the effect of elevated NEFA in vitro on the inhibition of hepatocyte gluconeogenesis (Li et al., 
2012).  Li et al., (2012) used quantitative PCR and spectrophotometry to show that when NEFA 
concentrations were higher than 0.5 and 1.5 mEq/L there was a marked decrease in mRNA levels 
of PC and PEPCK, respectively and when NEFA concentrations were higher than 1.5 and 0.5 
mEq/L there was a marked decreased in enzyme activity for PC and PEPCK, respectively.    
Hepatic lipidosis can severely compromise health and increase the risk of culling (Herdt, 
1988).  Although prior research has concentrated on the effects of fatty liver on the immune 
system, recent research has demonstrated that elevated levels of NEFA can also be detrimental to 
immune function (Contreras et al., 2010; Ster et al., 2012).    
Ketogenesis 
BHBA and NEB  
As discussed previously, excessive mobilization of fatty acids during the transition period 
leads to production of ketones.  Although the cause of hyperketonemia is not thoroughly 
understood, there are several theories proposed to help explain the progression of events.   
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Baird et al., (1968) presented the theory that the increased rate of gluconeogenesis during 
the transition period caused a decrease in OAA therefore an increase in ketogenesis; however, 
this theory was not supported.  Ballard et al., (1968) found that there were no changes in PC or 
OAA levels in cows that developed spontaneous ketosis versus normal cows.  Brown et al., 
(1992) hypothesized that ketogenesis was controlled by the principles of respiratory control such 
that substrate oxidation and ATP synthesis would proceed only as fast as needed to supply ATP 
for intracellular reactions, however, this was challenged by Berry et al., (1983) who 
demonstrated the reverse electron transport system in liver cells from rats, such that production 
of acetyl-CoA by beta-oxidation is obligatory linked to reverse electron transport.  If this reverse 
electron system is correct, it would explain why ketones continue to be produced as NEFA 
concentration increase (Cadorniga-Valino et al., 1997), however, it seems unlikely that this 
mechanism could operate in ruminants. The role of carnitine palmitoyltransferase (CPT I) in 
regulating transport of LCFA into the mitochondria for beta-oxidation in ruminants has been 
reported by several authors (Brindle et al., 1985; Jesse et al., 1986; Drackley et al., 1991).  
However, Dann et al., (2004), reported that in periparturient dairy cows neither activity of CPT I 
or its inhibition by malonyl-CoA was related to an induced ketosis.     
Drackley and Andersen (2006) reviewed the regulation of beta-oxidation and associated 
it with the disposal of acetyl-CoA in the mitochondria which can occur in three ways.  Acetyl-
CoA can be: 1. condensed with OAA to form citrate for complete oxidation of carbon dioxide in 
the TCA cycle; 2. used to form acetoacetyl-CoA in ketogenesis which results in release of 
acetoacetate (AcAc) that can be interconverted to BHBA with BHBA dehydrogenase; or 3. 
hydrolyzed by acetyl-CoA hydrolase which results in release of acetate from the mitochondria.  
Generally, it seems that ketone production seems to be a good avenue for utilization of the 
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acetyl-CoA derived from fatty acid beta-oxidation by helping decrease acetyl-CoA accumulation 
in the liver (Sato et al., 1999; Sugden et al., 2001).  Conversion of acetyl-CoA to ketones allows 
the liver to oxidize five times as much NEFA with the same ATP production as if acetyl-CoA 
were completely oxidized in the TCA cycle (Drackley and Andersen, 2006).   
Lastly, although the significance of peroxisomal beta-oxidation is controversial, this 
pathway may become more important when the mitochondrial beta-oxidative pathways are 
overloaded (Drackley and Andersen, 2006).  Recent research has demonstrated that cows fed 
high energy diets during the transition period develop insulin resistance (Grummer, 1995; 
Holtenius et al., 2003; Dann et al., 2006) which can lead to unchecked lipolysis.  These cows will 
have higher mobilization of adipose tissues, and in turn may overload the beta-oxidative 
pathways.     
In the lactating animal with concurrent NEB, the increased oxidation of fatty acids in the 
liver results in a low cytosolic NADH : NAD ratio.  Since conversion of AcAc to BHBA occurs 
in the cytosol, this ratio will impact the ratio of BHBA:AcAc released by the liver (Heitmann et 
al., 1987; Enjalbert et al., 2001).  In contrast to fasting animals where the BHBA:AcAc ratio is 
low due to production rather than intercoversion of AcAc, lactating animals have a higher 
BHBA:AcAc ratio (Mills et al., 1986).  These ratios are important when evaluating animals for 
hyperketonemia with different tests, such as milk ketone, urine, or blood.  Enjalbert et al., 2001, 
used blood BHBA concentration at > 12 mg/dL as the gold standard to define SCK and 
compared: blood acetone to acetoacetate tests; milk acetone to acetoacetate, and milk BHBA 
tests.  This study found that when these tests had high sensitivity (i.e., > 91%), but their 
specificities were low (57 to 84%).  These sensitivities and specificities resulted in low 
predictive value positive (33.8 to 57.9%) and relatively high predictive value negative (97 to 
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98.4%).  Additionally, when the correlation between tests (i.e., milk versus blood) was 
examined, the correlation coefficients were: milk acetone: blood acetone 0.96; milk AcAc: blood 
AcAc 0.74; and milk BHBA to blood BHBA 0.66.      
The lack of correlation of ketone concentrations between blood and milk measurements 
will dictate the cut-points used to call a test positive.  Recently, the Precision Xtra meter (Abott 
laboratories), a handheld device used to test blood BHBA concentrations was validated for use in 
ruminants.  The sensitivity and specificity compared to serum BHBA concentrations determined 
photometrically are 96% and 98%, respectively, when using a cut-off value of  ≥ 12 mg/dL 
(Iwersen et al., 2009; Konkol et al., 2009).  There are other ketone tests on the market with 
varying degrees of sensitivity and specificity.  For example: the Ketostix strip (Bayer 
Corporation, Elkhart, IN) evaluates acetoacetate in urine and when read after 5 seconds and 
interpreted as a “trace” had 90% sensitivity and 86% specificity and when interpreted as “small” 
has 78% sensitivity and 96% specificity both relative to serum at with BHBA ≥ 14 mg/dL 
(Carrier et al., 2004).  The Ketotest (Sanwa Kagaku Co. Ltd., Nagoya, Japan) for milk when read 
at ≥ 5 mg/dL relative to serum at ≥ 14 mg/dL has 88% sensitivity and 90% specificity (Carrier et 
al., 2004).  
Intervention strategies 
Sustain glucose production  
When an animal is experiencing excessive NEB, direct glucose administration will 
immediately provide glucose.  Although the exogenous glucose may help initially, cows respond 
to glucose infusions by increasing glucose utilization in adipose and skeletal tissue (Al-Trad et 
al., 2009).  Wagner et al., (2010) reviewed the effect of either 0.5 L or 1 L of 50% dextrose 
administration IV on NEFA, BHBA, glucose and insulin and reported that the activity of glucose 
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was short lived (<12 hours) and after 24 hours, NEFA and BHBA concentrations were back at 
subclinical ketosis levels.  Insulin concentrations were increased in both treatment groups when 
compared to the control, but it was higher in the cows that received 1 L of 50% dextrose when 
compared to those that received just 0.5 L.  In addition, dextrose treatment caused 
hypophosphatemia, which in early lactation cows, may exacerbate other mineral deficiencies.  It 
is therefore more advantageous to provide glucose precursors in order to alleviate NEB like 
monensin or propylene glycol.   
Ionophores, like monensin, increase glucose precursors because they alter rumen 
microbial populations such that microbes that produce propionate are over-represented in the 
rumen population (Bergen and Bates, 1984).  These ionophores have been used in lactating cows 
to increase the glucogenic precursor and thus alleviate some of the negative downstream 
outcomes associated with excessive NEB (Duffield et al., 2008a; Duffield et al., 2008b; Duffield 
et al., 2008c; McGuffey et al., 2001).  It is recommended to provide monensin starting a few 
weeks pre-partum until peak lactation (McGuffey et al., 2001). 
Propylyne glycol (PG) has been known to provide glucogenic effects since the 1950s 
(Johnson, 1954), more recently, Kristensen et al., (2007)  has demonstrated that an oral PG 
drench helps decrease glucose demand by peripheral tissues, despite the increase in insulin seen 
secondary to glucose increase.  Currently, PG is used in cows in early lactation to help decrease 
concentrations of NEFA and BHBA (Overton and Waldron, 2004; McArt et al., 2011).  More 
recently, McArt et al., (2011) showed that in cows that already had an increase in BHBA (BHBA 
≥ 1.2 mg/dL) but were not yet clinically ketotic, benefited from PG  administration and were less 
likely to develop clinical ketosis, more likely to resolve the SCK and produced more milk than 
the untreated controls.    
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Vitamin B12, was discussed previously, and has been used in conjunction with other 
ketosis treatments.  Its effectiveness is likely related to the fact that MCM (the enzyme 
associated with gluconeogenesis from propionate) depends on Vitamin B12 (Aschenbach et al., 
2010).   
Minimize Hepatic Lipidosis 
There are several feed additives that have been evaluated to help improve hepatic 
lipidosis by either improving the export of fat from the liver or decreasing TAG lipogenesis.   
Rumen-protected choline (RPC) may help hepatic export of fat in transition cows (Zom et al., 
2011), and it may increase DMI and milk production, however, the optimal dose that will 
provide the best effect is still under investigation (Piepenbrink and Overton, 2003; Zahra et al., 
2006; Zom et al., 2011).  Zahra et al., (2006) reviewed the effects of monensin and rumen 
protected choline and reported that only cows with BCS > 4 had increased milk production.   
Niacin supplementation has also been evaluated because it can suppress lipolysis, however, 
dietary treatment is inconsistent and feeding too much can decrease DMI which can exacerbate 
NEB (Morey et al., 2011).  Chromium potentiates the action of insulin and may also prevent 
lipolysis (Grummer, 2008); however, effects of chromium administration on metabolism were 
only modest (Smith et al., 2008).  Although additional research on feed additives may help 
alleviate some of the excessive lipolysis and hepatic lipidosis, perhaps the most effective 
mechanism of managing lipolysis is to manage the BCS over the dry period.  Overweight cows 
will have decreased DMI, elevated NEFA and BHBA concentrations post-partum, and are more 
likely to develop hepatic lipidosis (Holter et al., 1990; Van den Top et al., 1996). 
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General recommendations  
 Based on the previously reviewed literature, the current general management and 
nutritional recommendations to help improve the transition period is to have cows enter the dry 
period in good BCS, control energy demands during the dry period, minimize fat in the ration, 
minimize stress, maximize access to feed, and consider incorporating nutritional additives such 
as ionophores to help improve gluconeogenesis.  However, even if these recommendations are 
followed, it is important to monitor cows in the transition period so that changes in management 
or nutrition can be made without having to wait for the negative downstream outcomes that 
associated with excessive NEB.   In order to monitor transition cows, it is necessary to identify 
objective monitoring tools that are easy to use, inexpensive and accurate.     
ASSOCIATION BETWEEN EXCESSIVE NEFA AND BHBA, AND NEGATIVE 
DOWNSTREAM OUTCOMES AT INDIVIDUAL ANIMAL LEVEL 
Thus far, the evaluation of the transition period has focused on the process by which 
cows partition energy for lactogenesis despite having to enter a state of NEB.   There are 
adaptive mechanisms in place to deal with NEB during the post-partum period, and the negative 
effects on health, reproduction and milk production are in fact associated with excessive NEB, 
and excessive elevation of NEFA or BHBA can indicate poor adaptation to NEB (Andersson, 
1988; Herdt, 2000).  The measurement and monitoring of these metabolites has been advocated 
by several authors (which will be reviewed below) and has proven useful when evaluating a 
transition cow program because of the association between elevated metabolite levels and 
negative downstream outcomes (Oetzel, 2004; Duffield et al., 2009).    
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Disease outcomes 
As mentioned previously, both hepatic lipidosis and elevated NEFA and BHBA 
concentrations (Hoeben et al., 1997) have been associated with decreased immune function.   
Because cows are most likely to develop either an infection or metabolic disease early in 
lactation (LeBlanc et al., 2006), the association between excessive NEB and detrimental effects 
on the health of dairy cows during the transition period has been reviewed by several authors 
(Andersson, 1988; Kehrli et al., 1989; Hammon et al., 2006; Scalia et al., 2006).     
 Although the association between elevated concentration of the metabolites, NEFA and 
BHBA and detrimental effects was established, the critical threshold above which these 
detrimental effects were most likely was still under investigation.  Cameron et al., (1998)  
reported that along with a high BCS, high energy in the dry cow diet, and reduced bunk space, 
NEFA concentration > 3 mEq/L between 35 and 3 d pre-partum was associated with an 
increased risk of displaced abomasum (DA) in 1170 multiparous cows in herd in Michigan.  
LeBlanc et al., (2005), evaluated over 1,000 cows in mostly tie-stall herds in Canada and 
reported that cows with pre-partum NEFA concentrations ≥ 0.5 mEq/L were 3.6 times more 
likely to develop a DA post-partum than those with NEFA concentrations < 0.5 mEq/L, and 
when BHBA and NEFA were measured in the post-partum period, only BHBA and not NEFA, 
was significantly associated with the risk of developing a DA.  Cows with BHBA concentration 
≥ 12 mg/dL were 8 times more likely to develop a DA.  The methods for evaluating risk ratios 
(RR) versus odds ratios (OR), will be discussed in a later section, it is important to note that 
even though the previous study used logistic regression to evaluate the association between 
elevated metabolites and the development of a DA, the results were reported as RR.  In cases 
where the outcome is not rare, such as studies that investigate mastitis, the OR can overestimate 
the RR resulting in over-estimation of the true effect. 
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Another study on 24 Canadian farms demonstrated that cows in the first week post-
partum with elevated concentrations of BHBA (≥ 10 mg/dL) had 13.6 greater odds of developing 
a DA when compared to cows with BHBA below this concentration.  Those with post-partum 
NEFA concentrations ≥ 1.0 mEq/L, and post-partum BHBA ≥ 12 mg/dL were associated with 
6.3 and 4.7 greater odds of developing clinical ketosis, respectively (Seifi et al., 2011). 
More recently, Chapinal et al., (2011) evaluated the association between elevated NEFA 
and BHBA and negative downstream outcomes in a large multi-center study on 2365 cows, by 
sampling the same cohort of cows from 1 week pre-partum to 1 week post-partum and then 
recording disease incidence.  This group confirmed that cows with pre-partum NEFA 
concentrations ≥ 0.3 mEq/L and ≥ 0.5 mEq/L were more likely to develop retained placenta and 
metritis, respectively.  When evaluating the odds of developing a DA they found that cows with 
pre-partum NEFA ≥ 0.5mEq/L and post-partum NEFA ≥1.0 mEq/L had increased odds.  Pre-
partum BHBA was also evaluated and although the specificity was low, they found that if pre-
partum BHBA was ≥ 8.0 mg/dL, these cows had higher risk of developing a DA.  This group 
evaluated both pre- and post-partum energy status, and found that the combined information of 
NEFA concentrations both pre- and post-partum were better predictors of disease risk than 
BHBA.   The fact that information on NEFA pre- and post-partum was a better predictor than 
BHBA alone makes sense.  Cows that are mobilizing fat reserves during the dry period are likely 
to have a more detrimental transition.   
Although Chapinal et al., (2011) did not report on the ratio of NEFA to BHBA, an older 
study by Veenhuizen et al., (1991) reviewed NEFA and BHBA simultaneously.  Veenhuizen et 
al., (1991) found that NEFA concentrations were increased 3, 2.6, 1.9 times at 3 weeks, 2 weeks, 
and at ketosis diagnosis and BHBA concentrations were increased 3.5, 5.8, and 8.4 times at the 
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same time points in cows with experimentally induced ketosis, thus the change in BHBA 
concentration was much more pronounced than NEFA at similar time points.  Although studies 
with repeated measures may help us understand the physiology, the practical application to farms 
of this information may be limited.  On modern farms, multiple samples on individual cows 
during the transition period may not be feasible, therefore research on the ratio of NEFA to 
BHBA at one sampling point and its relationship to negative downstream outcomes may be more 
useful. 
Reproduction and milk production 
When evaluating reproduction and milk production, previous reports suggests that there 
is an association between milk yield and decreased fertility; however, the results were 
controversial. Some studies reported that higher producing cows had lower fertility (Butler, 
2003), whereas others did not (Hansen et al., 1983; Butler and Smith, 1989).  This unexplained 
contradiction between milk yield and fertility coupled with the concept of homeorhesis focused 
the investigation toward energy balance deficits during the transition period and their effect on 
fertility. A subsequent study revealed that there was an association between excessive NEB and 
decreased reproductive performance; however, that study only examined BHBA concentrations, 
did not evaluate NEFA, and did not define a concentration threshold above which detrimental 
downstream outcomes were most likely (Walsh et al., 2007).  Diminished reproductive effects 
may also be related to uterine disease (Reist et al., 2003; Hammon et al., 2006), and delayed 
luteal activity (Wathes et al., 2007), both of which have been shown to be associated with 
elevated BHBA concentrations.  Excessive NEB has also been linked to decreased milk yield 
(Duffield et al., 2009).  However, defining the level at which elevated NEFA or BHBA are 
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associated with milk production has been difficult because some elevation in these metabolites is 
characteristic of the transition period and because many other factors affect milk yield.  
Although milk production is a sink for energy, it is important to note that with the 
exception of mastitis, milk production is not necessarily associated with increased risk of disease 
(Erb and Grohn, 1988; Cameron et al., 1998; Grohn, 2000; Ingvartsen et al., 2003).  It is the 
individual animal response to these biological changes that dictate whether they will experience 
excessive NEB and thus be at higher risk of detrimental outcomes. Therefore it is important to 
explore the association between markers of NEB and milk production.  Duffield et al., (2009) 
described an objective BHBA concentration threshold for the prediction of milk yield early in 
lactation, but the effects of pre- or postpartum NEFA concentrations were not evaluated.  This 
group reported that cows with serum BHBA concentration ≥ 12 mg/dL measured during the first 
and second week post-partum made less milk.   
STATISTICAL METHODS 
Previous research which has evaluated the effects of elevated NEFA and BHBA during 
the transition has used statistical methods which estimated the OR.  The OR is frequently used 
because it is the estimable measure of association in some study designs (i.e., case-control 
studies) or because estimating a more appropriate measure of association such as the RR was not 
readily feasible with commercially available statistical packages. Although the OR and not the 
RR was estimated, instead of reporting the odds, the results were sometimes misinterpreted as 
RR and incorrect phrases such as “more likely” or “risk” were used to describe the association 
between the risk factor(s) and the outcome of interest.  Two problems are associated with 
estimating the OR in study designs where the RR can be estimated: (1) the OR can overestimate 
the true effect as the outcome becomes more common, and (2) interpretation of the OR is not 
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intuitive (Holcomb et al., 2001) because, unlike the RR, the OR does not directly measure effects 
on probability.   In response to these concerns, recently statistical methods for estimating the RR 
have been proposed.   
ASSOCIATION BETWEEN NEFA AND BHBA AND NEGATIVE DOWNSTREAM 
OUTCOMES AT THE HERD-LEVEL 
Objective cow-level thresholds have been determined for increased BHBA and NEFA 
concentrations that are associated with disease, and reproduction, and production outcomes 
(LeBlanc et al., 2005; Duffield et al., 2009; Ospina et al., 2010; Ospina et al., 2010; Chapinal et 
al., 2011). This information allows the identification of individual cows at risk for these 
downstream outcomes based on their NEB status during the transition period. However, despite 
all of the NEB information available at the cow-level and its association with downstream 
outcomes, individual cow strategies for prevention of subclinical disease are still a challenge 
(Duffield, 2000). This is in part because changes associated with NEB adaptation can start as 
early as 6 wk pre-partum (Drackley et al., 2001). Efforts to improve NEB status should be 
implemented at the herd-level, where decisions about nutritional management and other aspects 
of the environment and herd management that in turn affect pre- and post-partum groups of cattle 
can be addressed appropriately.  Unfortunately, information regarding the appropriate herd alarm 
levels (i.e., the proportion of sampled animals with increased concentrations of NEFA and 
BHBA) have not been well defined (Oetzel, 2004).  
When evaluating excessive NEB at the herd-level, pooled samples may seem desirable 
due to lower laboratory cost.  Although pooled samples are cost effective and useful in 
determining herd-level status for some infectious diseases, such as Mycobacterium  avium subsp. 
paratuberculosis and Bovine Viral Diarrhea (Munoz-Zanzi et al., 2000; van Schaik et al., 2003), 
the ability to correctly determine herd-level NEB status through pooling has been questioned.  
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Pooled samples are good estimates of the arithmetic means of individual samples (Tornquist and 
Van Saun, 1999) but may be misleading when evaluating herd NEB status because individual 
animals may have very high concentrations of either metabolite and this will directly affect the 
pooled sample concentration.  In addition, because animals have a normal baseline concentration 
for NEFA and BHBA and disease is associated when the metabolites are above a certain 
biological threshold (Oetzel, 2004) the arithmetic mean of the sample may not indicate that the 
herd has excessive NEB.   Further evaluation of testing strategies at the herd-level is warranted.  
CONCLUSIONS AND RESEARCH OBJECTIVES 
 The transition period is a very important time period for the dairy cow because, as 
discussed previously, the effects of excessive NEB can increase the risk of disease, can result in 
poor reproductive performance, and affect milk production.  Being able to monitor cows at both 
the individual and herd-level will help farms manage this time period more effectively.  
Objective thresholds above which cows are more likely to have negative downstream outcomes 
are necessary in order to evaluate different programs, and perhaps more importantly, herd-alarm 
levels are necessary. Herd-alarm levels would allow a herd to monitor cows at the group level 
since this is the level where most management strategies take effect.  Additionally, when a group 
of animals are evaluated it is important to address the idea of pooling samples.  Pooling may help 
reduce the cost of sampling, but it may reduce sensitivity or specificity, thus this should be 
explored.        
The objectives of this research were to: 
1. Establish cow-level critical thresholds for NEFA and BHBA concentrations to predict 
key periparturient disease conditions and  investigate the magnitude of the association of 
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these metabolites with disease conditions within 30 DIM in free-stall, TMR-fed herds in 
the northeastern United States.  
2. Evaluate the association between elevated pre- and postpartum NEFA and BHBA 
concentrations on reproductive performance and milk production and to establish the 
metabolite concentrations above which the effects were most likely to occur. 
3. Identify the herd alarm level for excessive NEB (i.e., the proportion of sampled animals 
with increased NEFA and BHBA) that was associated with herd-level changes in disease, 
reproduction and milk production.  
4. Explain why the RR is the preferred measure of association when the outcome of interest 
is dichotomous in both cohort studies and randomized trials and to outline an applied 
method for estimating the RR using SAS version 9.2 (SAS Institute Inc., Cary, NC). 
5. Compare the NEB status of a herd based on individual samples versus pooled samples 
using BHBA concentrations and estimate the herd level sensitivity and herd level 
specificity based on simulated individual animal sampling (varying sample size, 
underlying herd-level prevalence of elevated BHBA, and test sensitivity and specificity), 
and 3) estimate the herd predictive value positive and herd predictive value negative 
under the same simulation and discuss the frequency of sampling.           
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ABSTRACT  
The objectives of this study were to 1) establish cow- level critical thresholds for serum 
concentrations of non-esterified fatty acids (NEFA) and beta-hydroxybutyrate (BHBA) to 
predict periparturient diseases [displaced abomasa (DA), clinical ketosis (CK), metritis and 
retained placenta, or any of these three], and 2) investigate the magnitude of the metabolites’ 
association with these diseases within 30 d in milk.  In a prospective cohort study of 100 
freestall, total mixed ration-fed herds in the northeastern United States, blood samples were 
collected from approximately 15 pre-partum and 15 different post-partum transition animals in 
each herd, for a total of 2,758 samples.  Serum NEFA concentrations were measured in the pre-
partum group, and both NEFA and BHBA were measured in the postpartum group.  The critical 
thresholds for NEFA or BHBA were evaluated with receiver operator characteristic analysis for 
all diseases in both cohorts.  The risk ratios (RR) of a disease outcome given NEFA or BHBA 
concentrations and other covariates were modeled with multivariable regression techniques, 
accounting for clustering of cows within herds.  The NEFA critical threshold that predicted any 
of the 3 diseases in the pre-partum cohort was 0.29 mEq/L and in the postpartum cohort was 0.57 
mEq/L.  The critical threshold for serum BHBA in the post-partum cohort was 10 mg/dL, which 
predicted any of the 3 diseases.  All RR with NEFA as a predictor of disease were > 1.8; 
however, RR were greatest in animals sampled postpartum (e.g., RR for DA = 9.7; 95% CI = 4.2 
to 22.4.  All RR with BHBA as the predictor of disease were > 2.3 (e.g., RR for DA = 6.9; 95% 
CI = 3.7 to 12.9).  Although pre-partum NEFA and postpartum BHBA were both significantly 
associated with development of clinical disease post-partum serum NEFA concentration was 
most associated with the risk of developing DA, CK, metritis or retained placenta during the first 
30 d in milk.   
Keywords: dairy cow, nonesterified fatty acids, β-hydroxybutyrate, disease  
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INTRODUCTION  
Most transition dairy cows enter a state of negative energy balance (NEB) for 3 primary 
reasons: increased energy demands at parturition, decreased DMI shortly before parturition, and 
lagging DMI compared with energy demands due to milk production (Gerloff, 2000; Hayirli et 
al., 2002).  The energy need of a transition cow increases from approximately 1 kg/d of glucose 
during late gestation to 2.5 kg/d during the first 3 wk post-calving (Reynolds et al., 2003).  
Because of increased energy demand and decreased DMI, the transition cow must meet this 
challenge by mobilizing adipose tissue.  Some degree of NEB, which can be identified by an 
increase in circulating concentrations of NEFA and BHBA, is expected in the transition period as 
the cow adjusts to new energy demands and energy intake catches up with production.  Stored 
energy from fat is mobilized as NEFA, some of which is taken up by the liver.  In the liver some 
NEFA are oxidized or reesterified into triglycerides that are either exported as very low density 
lipoproteins or stored in the liver.  During the periparturient period, high rates of NEFA enter the 
liver and sometimes exceed the liver’s capacity to secrete triglycerides as very low density 
lipoproteins, resulting in an accumulation of triglycerides (Drackley et al., 2001).  Increased 
amounts of NEFA removed by the liver along with carnitine palmitoyltransferase-1 activity 
regulate ketogenesis and thus, BHBA production (Hegardt, 1999).   
Excessive NEB (ENEB) had detrimental effects on the health and production of dairy 
cows because of the suspected relationship between energy deficiency and immunosuppression 
(Kehrli et al., 1989; Hammon et al., 2006; Scalia et al., 2006).  Although a study in Ontario 
reviewed the association between ENEB and metabolic and reproductive disease in transition 
cows, that study focused on smaller, usually component-fed herds (Duffield et al., 1999).  The 
ability to predict at the cow level which animals are more likely to develop disease based on 
NEFA and BHBA concentrations might help producers prevent diseases proactively by focusing 
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on management and nutritional strategies to prevent subclinical and clinical disease.  The 
objectives were to 1) establish cow-level critical thresholds for NEFA and BHBA concentrations 
to predict key periparturient disease conditions, and 2) investigate the magnitude of the 
association of these metabolites with disease conditions within 30 DIM in free-stall, TMR-fed 
herds in the northeastern United States.  The periparturient conditions investigated were 1) 
displaced abomasum (DA), 2) clinical ketosis (CK), 3) either retained placenta (RP) or metritis 
(MET) or both, or 4) any of these 3 disease conditions.   
MATERIALS AND METHODS  
Study Population and Study Design  
A prospective cohort study was conducted from a convenience sample of 104 dairy herds 
in New York, Pennsylvania, and Vermont between January 2006 and July 2007.  Inclusion 
criteria for herds were 1) >250 milking cows, 2) free-stall housing, 3) fed a TMR, and 4) 
participated in DHIA or used Dairy Comp 305 (version 2009; Valley Ag Software, Tulare, CA) 
or both.   
A convenience sample of apparently healthy heifers and cows in the transition period 
were selected.  At the time of sample collection, healthy heifers or cows were defined as not 
being in the sick pen, not currently receiving any medical treatment, and not displaying sick cow 
behavior based on the subjective interpretation of the research staff.  At sample collection, 2 
cohorts of animals were identified: those 14 to 2 d prepartum and those 3 to 14 d postpartum.  In 
each herd, cross-sectional sampling of approximately 15 animals from each group was done to 
achieve approximately 90% confidence of within-herd prevalence.  To reflect common herd 
demographics, approximately one-third of the animals sampled were primiparous (both before 
and after first parturition).   
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Animals were followed through 30 DIM for incidence of the selected periparturient 
diseases.  In the cohort sampled prepartum, the diseases of interest were DA, CK, and MET or 
RP, a combination of RP and MET, and any combination of the 3.  In the cohort sampled 
postpartum, diseases of interest were DA, CK, MET, and any combination of these 3.  Metritis 
and RP were evaluated as one disease in animals sampled prepartum because of possible 
misclassification of metritis.  Retained placenta was not evaluated in the cohort sampled 
postpartum because cows sampled at 3 to 14 DIM were no longer at risk for RP.   
Farm Survey and Case Definitions  
Efforts were made to limit differences between farms on all levels of data collection.  All 
farmers received a standardized consent form, survey, and case definitions for diseases of 
interest.  All farmers consented to participate, and the study was approved by the Cornell 
University Institutional Animal Care and Use Committee.  The survey included demographic 
information, and feeding times in relation to blood collection (Eicher et al., 1999) to be used as 
potential risk factors.  Farm personnel were instructed to document any incident cases of diseases 
both on the farm survey and in Dairy Comp 305.  Specifically, they were to document cases of 
DA, CK, and MET or RP.   
For consistency of documentation, the diseases were defined and case definitions were 
provided to farm personnel: 1) DA = movement of the fourth compartment of the stomach to a 
location on the right (RDA) or left side (LDA) of the cow and detected by ausculting a “ping” 
sound with finger percussion.  Often, a cow had an abrupt decrease in milk production and was 
off feed; 2) CK = cow that was off feed, had sudden weight loss, and decreased milk production, 
but had no other detectable signs of disease and was treated with dextrose, propylene glycol, 
steroids, or a combination (Duffield et al., 1999); 3) MET = sick cow (dull, decreased milk yield) 
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that had a fever greater than 39.5°C with a fetid (purulent or red to brown color or both) 
discharge from the vulva and was <21 DIM (Sheldon et al., 2006); and 4) RP = failure to expel 
fetal membranes within 24 h after calving.   
Blood Collection and Analysis  
Blood samples were collected from each cow and BCS were assigned (Ferguson et al., 
1994) concurrently with blood sample collection.  Guidelines for blood collection and sample 
handling were based on Stokol and Nydam (2005).  Briefly, a plain evacuated red-top tube was 
used to collect 10 mL of blood from the coccygeal vein or artery.  The blood was stored in a 
cooler (4°C), separated from cells within 24 h, and analyzed at the Cornell Animal Health 
Diagnostic Center (Ithaca, NY) within 48 h of collection.  All samples were analyzed using an 
automated wet chemistry analyzer (Hitachi 917, Roche Diagnostics, Indianapolis, IN).  The sera 
from the pre-partum cohort were analyzed for NEFA (NEFA-C, Wako Chemicals USA Inc., 
Richmond, VA) and hemolysis (Stokol and Nydam, 2006).  The sera from animals sampled 
postpartum were analyzed for NEFA, BHBA (β-HB, Catachem Inc., Bridgeport, CT), and 
hemolysis.   
Individual animal observations were excluded for the following reasons: the sample was 
severely hemolysed (Stokol and Nydam, 2006) or day of sample collection was out of sampling 
range for inclusion; for example, animals that were >14 d prepartum when sampled or >14 DIM 
at the time of sample collection.   
Statistical Analysis  
Multivariable Analysis.  Concentrations of NEFA and BHBA were the main risk factors 
of interest in the evaluation of the development of any combination of the diseases.  At this level 
of analysis, the metabolites NEFA and BHBA were treated as continuous variables.  The other 
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covariates considered were parity, season, BCS, time of blood collection in relation to feeding, 
and all biologically plausible 2-way interactions.  They were modeled with PROC GENMOD 
using a Poisson distribution, a log link function, p-scale option for over-dispersion, and an 
exchangeable correlation matrix (Spiegelman and Hertzmark, 2005).  There was no adjustment 
for varying time spans (offset term) because the length of the time interval was the same for 
every individual in the sample (Allison, 1999).  This statistical method allowed for clustering of 
cows within herds (i.e., including herd as a random effect) while adjusting for continuous or 
categorical covariates.   
Three full models (1 for animals sampled prepartum and 2 for animals sampled 
postpartum) were evaluated to predict the development of any combination of the diseases.  The 
models were 1) prepartum NEFA, covariates, and biologically plausible 2-way interactions 
between main effects and covariates, 2) postpartum NEFA, BHBA, covariates, and 2-way 
interactions, and 3) BHBA, covariates, and 2-way interactions in animals sampled postpartum.  
Beta-Hydroxybutyrate is easily measured on dairy farms using point-of-care analyzers; therefore, 
its effect was evaluated in a model without NEFA.  Covariates and interactions that were not 
significant at P > 0.10 were removed by manual backward stepwise elimination.   
Receiver Operator Characteristic Analysis for Critical Thresholds.   
The continuous variables that remained in the final multivariable model were evaluated 
with receiver operator characteristic (ROC) analysis to determine a critical threshold for 
predicting disease.  The ROC curves analyze sensitivity versus 100 - specificity.  Sensitivity was 
the proportion of animals diagnosed with disease that were above a given metabolite threshold, 
and specificity was the proportion of animals that did not have the diseases that was below a 
given threshold (Greiner et al., 2000).  The point on the ROC curve that had the highest combined 
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sensitivity and specificity was considered the critical threshold.  Interpretation of this critical 
threshold was based on the area under the curve (AUC) such that if the AUC = 0.5 it was non-
informative; if 0.5 < AUC ≤0.7, it was accurate; if 0.7 < AUC ≤0.9, it was very accurate; if 0.9 < 
AUC <1, it was highly accurate; and if AUC = 1, then it was considered perfect (Swets, 1988).  
The significant predictor variables from the multivariable analysis were analyzed using ROC 
curves to determine the critical thresholds for both individual diseases and any combination of 
those diseases.   
Likelihood ratios (LR) were evaluated.  The LR positive (LR+) was the probability that a 
test result at or above the threshold would be more likely to come from an animal later diagnosed 
with disease.   
Measures of Association.   
Risk ratios (RR) were modeled with PROC GENMOD, with a Poisson distribution, a log 
link function, p-scale option for over-dispersion adjustment, and an exchangeable correlation 
matrix (Spiegelman and Hertzmark, 2005).  At this level of analysis the significant covariates, 
NEFA and BHBA, were treated as categorical variables based on the thresholds from ROC 
analysis.   
Statistical analyses of data were conducted using SAS version 9.1 (SAS Institute, 2004), 
and ROC curves were obtained using MedCalc version 9.5.2.0 (Schoonjans, Mariakerke, 
Belgium).  All data were stratified based on prepartum or postpartum status at time of sample 
collection.   
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RESULTS  
Descriptive Data  
Of the 104 herds, 4 were excluded from the study because of missing data.  There were 
2,758 cows from the remaining 100 herds included and of these cows, 1,440 were sampled 
prepartum (35% heifers and 65% cows) and 1,318 were sampled postpartum (37% heifers and 
63% cows).  The number of milking cows per herd ranged from 265 to 2,770, with a median of 
767 and mean of 840.   
In animals sampled pre-partum, the lactational incidence of each disease condition was as 
follows: DA, 3.3%; CK, 7.0%; MET or RP, 12.1%; and any combination of these 3 conditions, 
19.6%.  In animals sampled postpartum, the lactational incidences were as follows: DA, 3.1%; 
CK, 4.6%; MET, 2.9%; and any combination, 9.0%.  The median DIM at diagnosis for diseases 
in animals sampled pre-partum were DA 10, CK 7, MET 5, and RP 2.  The median DIM at 
diagnosis for diseases in animals sampled post-partum were DA 15, CK 11, and MET 9.  The 
median BCS for heifers sampled pre-partum was 4 (range: 2 to 4.75) and for cows 3.5 (2 to 4.5).  
The median BCS for heifers sampled post-partum was 3.5 (2 to 4.5) and for cows 3.25 (1.75 to 
4.5).   
Multivariable Analysis  
In the multivariable model for animals sampled pre-partum, NEFA (P = 0.03) was the 
only predictor retained in the model, and there were no interactions with P < 0.16.  In the 
postpartum multivariable model with NEFA (P = 0.0005) and BHBA (P = 0.29), NEFA was the 
only predictor retained.  When, in a third model, BHBA (P = 0.005) was modeled as the main 
effect without NEFA, it was the only predictor retained and no interactions had a P < 0.16.   
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Critical Thresholds  
Nonesterified fatty acids and BHBA were the only significant predictors identified in the 
multivariable models.  They were then analyzed with ROC curves to determine the cow-level 
critical thresholds (combined highest sensitivity and specificity) to predict individual diseases as 
well as any combination of the diseases.  Tabular results of ROC curve determination of critical 
NEFA (mEq/L) thresholds for the prediction of individual diseases as well as the combination of 
diseases are in Table 2.1. 
 In summary, for the prediction of the development of any disease, the pre-partum NEFA 
critical threshold was 0.29 mEq/L and the postpartum NEFA threshold was 0.57 mEq/L.  Figure 
2.1 is a graphical example of a ROC curve with NEFA as a predictor of DA in animals sampled 
postpartum.  As a test for the prediction of DA, additional information on various levels of NEFA 
are in Table 2.2, showing sensitivity, specificity, and LR for various levels of pre-partum and 
postpartum NEFA used for comparison with other studies and to provide additional information 
to readers.   
Results for BHBA concentrations (mg/dL) are reported similarly.  Table 2.3 identifies the 
critical BHBA thresholds in animals sampled post-partum when predicting individual diseases as 
well as any of the diseases.  Briefly, the critical threshold for predicting any disease was 10 
mg/dL.  Table 2.4 provides additional information on various levels of BHBA as a test for 
prediction of DA.  Likelihood ratios were calculated based on critical thresholds determined by 
univariable ROC analysis and reported in Tables 2.1 to 2.4.  In general, the LR+ reports the 
probability that a test result at or above a given threshold will have a greater chance of coming 
from an animal later diagnosed with disease.  For example, the post-partum NEFA optimal 
threshold for predicting DA was 0.72 mEq/L; this resulted in 3.0 LR+.  The interpretation is that 
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a NEFA test value at or above this threshold (0.72 mEq/L) was 3 times as likely to come from a 
cow that was later diagnosed with DA. 
Measures of Association 
Risk ratios were calculated using multivariable modeling after critical thresholds were 
determined in ROC analysis (Tables 2.5 and 2.6).  All RR were significant and >1.8.  In the 
cohort sampled pre-partum, all risk ratios were >1.8 (range: 1.8 to 2.2; Table 5), meaning, for 
example, that the risk of getting any of the diseases later was at least 1.8 times greater in cows 
with a NEFA concentration higher than the threshold value (0.29 mEq/L).  In the cohort sampled 
postpartum, all NEFA risk ratios were >4.4 (range: 4.4 to 17).  An example of one of the larger 
risk ratios is the one associated with developing a DA, where cows with postpartum NEFA ≥0.72 
mEq/L were almost 10 times more likely to develop a DA within 30 DIM.  Risk ratios based on 
BHBA concentrations were significant and >2.3 (2.3 to 6.9, Table 2.6) meaning that there was a 
higher risk of developing disease if animals had a BHBA level higher than the threshold. 
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Table 2.1 Receiver operator characteristic (ROC) curve determination of critical Non-esterified 
Fatty Acids (NEFA) thresholds as predictors of disease in transition dairy cows.    
Animals sampled pre-partum (n = 1440) 
Disease Critical 
threshold1 
Sen2 95% CI3 
for Sen 
Spec4 95% CI 
for Spec 
LR +5 AUC6 P 
DA 0.27 57 42 to 72 62 60 to 65 1.5 0.6 0.01 
CK 0.26 53 43 to 64 61 58 to 64 1.4 0.6 0.001 
MET or 
RP or both 
0.37 37 30 to 45 80 78 to 83 1.9 0.6 0.0001 
Any 3 0.29 48 42 to 54 69 67 to 72 1.6 0.6 < 0.0001 
Animals sampled post-partum (n = 1318) 
DA 0.72 80 65 to 91 73 70 to 75 3.0 0.8 < 0.0001 
CK 0.57 74 61 to 84 59 57 to 62 1.8 0.7 < 0.0001 
MET 0.36 97 86 to 100 30 28 to 33 1.4 0.6 0.009 
Any 3 0.57 75 66 to 82 61 58 to 64 1.9 0.7 < 0.0001 
1 Highest combined specificity and sensitivity, mEq/L  
2 Sen = epidemiologic sensitivity       
3 CI = Confidence Interval  
4 Spec = epidemiologic specificity  
5 Likelihood ratio positive      
6 AUC = Area under the curve  
 
Table 2.2. Additional information on cut-points from receiver operator 
characteristic (ROC) curves for Non-esterified Fatty Acids (NEFA) concentrations 
as predictors of DA.   
Animals sampled pre-partum (n = 1440) 
Thresholds 
(mEq/L) 
Sensitivity 95% CI1 for 
Sensitivity 
Specificity 95% CI for 
Specificity 
LR +2 
0.2 64 49 to 73 48 45 to 51 1.2 
0.273 57 42 to 72 62 60 to 65 1.5 
0.4 30 17 to 45 82 80 to 84 1.7 
0.5 23 12 to 38 89 87 to 91 2.2 
Animals sampled post-partum (n = 1318) 
0.4 95 83 to 99 39 37 to 42 1.6 
0.723 80 65 to 91 73 70 to 75 3.0 
1.02 59 42 to 74 87 85 to 89 4.6 
1 CI = Confidence interval 
2 Likelihood ratio positive  
3 Highest combined sensitivity and specificity in this study 
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Table 2.3.  Receiver operator characteristic (ROC) curve determination of critical β-
hydroxybutyrate (BHB) thresholds as predictors of disease in transition dairy cows.    
Animals sampled post-partum (n = 1318) 
Disease Critical 
threshold 1 
Sen2 95 % CI3 
for Sen 
Spec4 95 % CI 
for Spec 
LR +5 AUC6 P 
DA 10 71 55 to 84 80 77 to 82 3.5 0.8 < 0.0001 
CK 10 57 44 to 70 80 78 to 82 2.8 0.7 < 0.0001 
MET 7 63 46 to 78 59 56 to 61 1.5 0.6 0.03 
Any 3 10 57 47 to 66 82 79 to 84 3.1 0.7 < 0.0001 
1 Highest combined specificity and sensitivity, mg/Dl 
2 Sen = Epidemiologic sensitivity       
3 CI = Confidence Interval  
4 Spec = Epidemiologic specificity  
5 Likelihood ratio positive      
6 AUC = Area under the curve   
 
 
 
 
 
 
 
 
  
Table 2.4. Additional information on cut-points from receiver operator 
characteristic (ROC) curves for β-hydroxybutyrate (BHB) concentrations as 
predictors of DA in animals sampled post-partum.    
Animals sampled post-partum (n = 1318) 
Threshold 
(mg/dL) 
Sensitivity 95 % CI1 for 
Sensitivity 
Specificity 95 % CI for 
Specificity 
LR +2 
8 76 60 to 88 69 67 to 72 2.5 
103 71 55 to 84 80 77 to 82 3.5 
12 63 47 to 78 86 84 to 88 4.6 
14 51 35 to 67 90 88 to 91 4.9 
1Confidence Interval  
2 Likelihood ratio positive  
3 Highest combined sensitivity and specificity   
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Table 2.5. Risk ratios of disease based on Non-esterified Fatty Acids (NEFA) 
critical thresholds derived from ROC curve analysis. 
Animals sampled pre-partum (n = 1440) 
Disease 
 
 
Critical 
threshold 
(mEq/L) 
Estimate SE1 P2 RR3 95% CI4 
DA 0.27 0.68 0.32 0.03 2.0 1.1 to 3.7 
CK 0.26 0.56 0.18 0.001 1.8 1.2 to 2.5 
MET or RP 
or both 
0.37 0.78 0.17 < 0.0001 2.2 1.6 to 3.0 
any of 
the 3 
0.29 0.56 0.12 < 0.0001 1.8 1.4 to 2.2 
Animals sampled post-partum (n = 1318) 
DA 0.72 2.3 0.43 < 0.0001 9.7 4.2 to 22 
CK 0.57 1.6 0.41 < 0.0001 5.0 2.3 to 11 
MET 0.36 2.8 1.1 0.008 17 2 to 134 
any of 
the 3 
0.57 1.5 0.26 < 0.0001 4.4 2.6 to 7.3 
1 SE = Standard error for estimate   
2 P-Value reported for estimate    
3 RR = Risk ratio   
4 CI = Confidence interval for RR  
 
Table 2.6. Risk ratios of disease based on post-partum β-hydroxybutyrate (BHB) 
critical thresholds derived from ROC curve analysis. 
Animals sampled post-partum (n =1318) 
Disease 
 
Critical 
threshold 
(mg/dL) 
Estimate SE1 P2 RR3 95% CI4 
DA 10 1.9 0.32 < 0.0001 6.9 3.7 to 12.9 
CK 10 1.6 0.21 < 0.0001 4.9 3.2 to 7.3 
MET 7 0.85 0.41 0.04 2.3 1.1 to 5.2 
any of the 3 10 1.5 0.18 < 0.0001 4.4 3.1 to 6.3 
1 SE = Standard error for estimate   
2 Values reported for estimate   
3 RR = Risk ratio   
4 CI =  Confidence Interval for RR 
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Figure 2.1. ROC curve determination of critical threshold (upper most left hand corner   ) for 
Non-esterified Fatty Acids (NEFA) concentrations (≥ 0.72 mEq/L) predicting DA in animals 
sampled post-partum. The diagonal line represents the sensitivity and specificity level at which 
the test is non-informative. 
 
DISCUSSION 
The analytical approach used to examine the association between both pre- and 
postpartum NEFA and postpartum BHBA and the development of several diseases in transition 
cows allowed reporting the RR directly rather than approximating it with odds ratios.  The ROC 
curves were used to determine the critical thresholds of the metabolites as predictors of diseases 
in TMR-fed, free-stall herds milking an average of 840 cows.  The results generally support other 
reports of transition cow disease: elevated NEFA and BHBA concentrations were associated with 
the development of the diseases of interest (DA, CK, MET or RP).  This association was reported 
by Dohoo and Martin (1984) who examined the association between subclinical ketosis and 
production and disease.  Cameron et al., (1998) and LeBlanc et al., (2005) explored this 
association with DA as the outcome and determined that elevated metabolite levels were 
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predictive of disease.  Duffield et al., (2002) reported that improved energy metabolism reduced 
the incidence of DA and RP, confirming the association between the 2 factors.  Kaneene et al., 
(1997) and Oetzel (2004) reported similar relationships.   
Concentrations of NEFA and BHBA were the main risk factors for predictors of disease 
after controlling for the random effect of herd, parity, season, BCS, sample collection time before 
feeding, and all biologically plausible 2-way interactions.  There were no significant interactions 
between the main effects and other covariates.  Neither BCS nor its interaction with metabolites 
was significant.  This is not surprising because it was the loss of body condition that was most 
closely related to problems with ENEB (Busato et al., 2002; Kim and Suh, 2003).  Beta-
Hydroxybutyrate concentrations fluctuate throughout the day and are generally highest 4 to 5 h 
after feeding, whereas NEFA concentrations are generally highest before feeding (Oetzel, 2004).  
Previous studies show that NEFA is less sensitive to time of sample collection, whereas BHBA is 
more sensitive (Eicher et al., 1999).  In this study, the interaction between the metabolites NEFA 
and BHBA and the timing of blood collection relative to feeding were not significant.  Days in 
milk or number of days before parturition were not included as covariates because the objective 
was to identify the critical threshold for the specified time frame, not describe the difference in 
metabolite levels based on DIM or days until parturition. 
In general, LR+ increased as metabolite levels increased.  Biologically this is logical 
because circulating NEFA and BHBA serum concentrations can be used as markers of energy 
status.  Therefore, levels above a given threshold should have a positive relationship with the 
probability of developing disease (i.e., higher metabolite levels are more predictive of disease).  
The LR related to DA and prepartum NEFA (LR = 1.5), postpartum NEFA (LR = 3), and 
BHBA (LR = 3.5) supported results from other studies.  For example, LeBlanc et al., (2005) 
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reported that a prepartum NEFA test result ≥0.5 mEq/L was twice (LR = 1.9) as likely to come 
from a cow later diagnosed with LDA as from one without an LDA; similarly they reported that 
a postpartum NEFA test result ≥1.0 mEq/L was 3.5 times as likely to come from a cow later 
diagnosed with an LDA.  In Duffield et al., (2009), test results of BHBA concentration ≥12 
mg/dL measured 1 wk postpartum were 1.87 times as likely to come from a cow later diagnosed 
with LDA.  Yet, in comparison to LR where there was a high prior probability of having the 
condition in question, these LR were low. 
Risk ratios were reported as measures of association between the metabolites (NEFA or 
BHBA) and disease outcomes.  An RR >1 indicated that animals with metabolite levels above the 
critical threshold (exposed group) were at higher risk for development of the disease than the 
animals below the critical threshold (unexposed group).  When NEFA was evaluated as predictor 
of DA in animals sampled postpartum, the risk ratio was 9.7; that is, animals sampled between 3 
to 14 DIM with a NEFA level ≥0.72 mEq/L were approximately 10 times more likely to develop 
a DA than animals below this threshold.  In general, postpartum NEFA concentrations resulted in 
the largest RR compared with those reported for prepartum NEFA and BHBA in this and other 
studies (Kaneene et al., 1997; Cameron et al., 1998; LeBlanc et al., 2005).  When BHBA was 
evaluated as the main predictor of disease, all RR were significant. 
The critical thresholds at which the metabolites were predictive of disease were lower 
than in previous reports.  Some previous studies sampled over different time frames and focused 
on different populations, often smaller, component-fed herds.  LeBlanc et al., (2005) sampled 
cows 10 to 4 d prepartum, in small, often component-fed herds and reported that the critical 
threshold for predicting an LDA with NEFA was at ≥0.5 mEq/L, with an odds ratio of 3.6.  They 
found that animals sampled up to 1 wk postpartum with NEFA ≥1 mEq/L yielded an odds ratio of 
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4.8; and a BHBA concentration of ≥12 mg/dL resulted in an odds ratio of 8.  Kaneene et al, 
(1997) did not report a critical value for NEFA or BHBA, but animals sampled postpartum (3 to 
35 DIM) presented a probable association between metabolic events associated with energy 
insufficiency and the risk of MET and RP.  In high-producing Michigan dairies, Cameron et al., 
(1998) sampled animals 3 to 35 d prepartum and found that animals with NEFA >0.3 mEq/L 
were twice as likely to develop an LDA.  Sampling from the first week postpartum, Geishauser et 
al., (2000) reported that the odds of developing a LDA were 4 times higher in animals with 
BHBA levels ≥14 mg/dL.  They reported that if BHBA was at this level in the second week 
postpartum, the odds were 8:1 that animals would develop an LDA. 
There were some limitations to this study including possible disease misclassification and 
loss to follow-up.  Although several steps were taken to prevent disease misclassification (e.g., 
case definitions and careful monitoring), MET may not have been properly diagnosed in all 
groups.  Metritis can be difficult to diagnose, especially if it coincides with RP.  Cases of CK 
may have been misclassified because ketone levels were not directly measured.  Loss to follow-
up is a limitation inherent to prospective cohort studies.  A small degree of loss to follow-up was 
experienced because cows from 4 farms were excluded due to missing cow disease information.  
At the cow level in the postpartum cohort, cows that were sick at time of sample collection were 
not eligible to be part of the study.  This may have influenced the median DIM at disease 
diagnosis.  In addition, as many cows as intended were not sampled in all herds for several 
reasons: smaller herds did not have enough eligible cows at time of sampling and some samples 
were discarded because of hemolysis. 
Postpartum NEFA had a higher association with the development of disease than did 
prepartum NEFA or postpartum BHBA as reflected by larger RR.  This association suggested 
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that the energy status as measured by NEFA from animals sampled postpartum (3 to 14 DIM) 
may have a more direct association with the development of disease than their energy status 
measured by BHBA or prepartum NEFA.  When compared with prepartum NEFA, time of 
sample collection may play a role: samples collected postpartum were temporally much closer to 
the disease event and were perhaps better able to predict this event.  Postpartum NEFA 
concentration as a predictor of disease has not been investigated as thoroughly as BHBA 
concentration or prepartum NEFA concentration.  The AUC values from ROC analysis coupled 
with larger risk ratios suggested that postpartum NEFA could be used similarly to BHBA and 
prepartum NEFA 
CONCLUSION 
The effects of elevated concentrations of NEFA and BHBA in the transition period 
predicted clinical disease (e.g., DA, CK, MET, or RP) in cattle from TMR-fed northeastern US 
free-stall dairies with an average of 840 cows.  The following cow-level critical thresholds should 
be considered general guidelines for monitoring cattle: NEFA concentrations ≥0.3 mEq/L for 
cattle 14 to 2 d prepartum; and NEFA concentrations ≥0.6 mEq/L and BHBA ≥10 mg/dL for 
cattle 3 to 14 d postpartum.  Both pre- and postpartum NEFA concentrations and BHBA 
concentrations above these critical thresholds were associated with increased risk for subsequent 
disease. 
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ABSTRACT 
The objectives were to evaluate the effects of elevated pre- and post-partum non-
esterified fatty acids (NEFA) and beta-hydroxybutyrate (BHBA) concentrations during the 
transition period on reproductive performance and milk production in dairy cattle.  In a 
prospective cohort study of 91 freestall, total mixed ration-fed herds in the northeastern United 
States, blood samples were collected from approximately 15 pre-partum and 15 different post-
partum transition animals in each herd.  All samples were stratified based on pre- or post-partum 
status at the time of sample collection, and 2,259 and 2,290 animals were used to evaluate 
reproductive and milk production performance, respectively.  Reproductive performance was 
assessed by time to conception within 70 d post-voluntary waiting period (VWP) and milk 
production was assessed using mature-equivalent 305-d (ME305) milk yield estimated at 120 d 
in milk.  While controlling for body condition score (BCS), calving season, median ME305 milk 
production, and parity, NEFA and BHBA concentrations were evaluated with time to event 
analysis to investigate reproductive performance.  These same predictor variables were used to 
determine the effects of elevated NEFA and BHBA concentrations on ME305 milk yield with 
herd as a random effect.  Heifers and cows were grouped in the final analyses if the results 
between groups were similar.  In all animals sampled pre-partum, the risk of pregnancy within 
70 d post-VWP was reduced by 19% when NEFA concentrations were ≥0.27 mEq/L.  In all 
animals sampled post-partum, those with NEFA concentrations ≥0.72 mEq/L had a 16% 
decrease in risk of pregnancy and those with BHBA concentrations ≥10 mg/dL had a 13% 
decrease in risk.  In cows and heifers, ME305 milk yield was decreased by 683 kg when pre-
partum NEFA concentrations were ≥0.33 mEq/L.  In heifers sampled post-partum, ME305 milk 
yield was increased by 488kg when NEFA concentrations were ≥0.57 mEq/L and increased by 
403 kg when BHBA concentrations were ≥9mg/dL.  In cows sampled post-partum, ME305 milk 
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yield was decreased by 647 kg when NEFA concentrations were ≥0.72 mEq/L and decreased by 
393 kg when BHBA concentrations were ≥10 mg/dL.  With the exception of milk production in 
heifers, this study indicates that increased concentrations of serum NEFA and BHBA had a 
detrimental effect on reproductive performance and milk production. 
Key words: nonesterifiedfattyacids, beta-hydroxybutyrate, milk production, pregnancy 
INTRODUCTION 
The ability of dairy cattle to partition available energy for milk production at the expense 
of reproduction early in lactation has made the role of energy balance a key factor in the study of 
reproductive performance and milk production.  The concept of prioritization of energy and other 
nutrients, also known as homeorhesis, was described in 1980 (Bauman and Currie, 1980) and has 
set the foundation for the study of negative energy balance (NEB) in transition dairy cattle.  The 
circulating metabolites non esterified fatty acids (NEFA) and beta-hydroxybutyrate (BHBA) are 
commonly used indices of NEB or ketosis in transition animals.  Although some elevation of 
these metabolites is normal as these animals balance energy intake and energy demands in early 
lactation, excessive elevation of NEFA or BHBA can indicate poor adaptation to NEB 
(Herdt,2000). 
Previous reports suggest   that there is an association between milk yield and decreased 
fertility; however, the results were controversial.  Some studies reported that higher producing 
cows had lower fertility (Butler,2003), whereas others did not (Hansen et al., 1983b; Butler and 
Smith, 1989).  This unexplained contradiction between milk yield and fertility coupled with the 
concept of homeorhesis focused the investigation toward energy balance deficits during the 
transition period and their effect on fertility.  Subsequent studies revealed that there was an 
association between excessive NEB and decreased reproductive performance (Walsh et al., 
2007); however, that study only examined BHBA concentrations, did not evaluate NEFA, and 
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did not define a concentration threshold above which detrimental downstream outcomes were 
most likely.  Diminished reproductive effects may also be related to uterine disease (Reist et al., 
2003; Hammon et al., 2006), and delayed luteal activity (Wathes et al., 2007), both of which 
have been shown to be associated with elevated BHBA concentrations. 
Excessive NEB has also been linked to milk yield (Duffield et al., 2009).  However, 
defining the level at which elevated NEFA or BHBA are associated with milk production has 
been difficult because some elevation in these metabolites is characteristic of the transition 
period and because many other factors affect milk yield.  Duffield et al., (2009) described an 
objective BHBA concentration threshold for the prediction of milk yield early in lactation but the 
effects of pre- or post-partum NEFA concentrations were not evaluated. 
The objectives were to evaluate the association between elevated pre- and post-partum 
NEFA and BHBA concentrations on reproductive performance and milk production and to 
establish the metabolite concentrations above which the effects were most likely to occur. 
MATERIALS AND METHODS 
Study Population and Study Design 
A prospective cohort study of progressive dairy herds in the northeastern United States 
was conducted using a convenience sample of 100 dairy herds.  To be included, a herd must have 
1) had more than 250 milking cows, 2) had free-stall housing, 3) fed a TMR, and 4) participated 
in DHIA or used Dairy Comp 305 (Valley Ag Software, Tulare, CA).  Herds were excluded from 
the study if information on herd pregnancy rate was not available and individual animals were 
excluded from the study if culling data or mature-equivalent 305-d (ME305) milk yield data at 
120 DIM were not complete. 
In each herd, 2 separate cohorts of animals were sampled on the same day: those 14 to 2 
d pre-partum and those 3 to 14 d post-partum.  A representative herd sample was obtained by 
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cross-sectional sampling of approximately 15 apparently healthy animals from each cohort.  
Sampling 15 animals would give 90% confidence   that the sample represents the true within-
herd prevalence.  Healthy was defined as not being in the sick pen, not currently receiving any 
medical treatment, and not displaying sick cow signs based on the investigators’ interpretation. 
To reflect common herd demographics, approximately one third of the animals sampled were 
primiparous. 
Ten-milliliter blood samples were collected into plain redtop evacuated tubes from each 
animal’s coccygeal vessel and handled according to recommendations (Stokol and Nydam, 
2005).  Concentrations of NEFA and BHBA were measured in serum using standardized 
reagents (NEFA-C, Wako Chemicals USA Inc., Richmond, VA; β-HB, Catachem Inc., 
Bridgeport, CT) and an automated wet chemistry analyzer (Hitachi 917, Roche Diagnostics, 
Indianapolis, IN).  The sera from the pre-partum cohort were analyzed for NEFA and hemolysis 
(Stokol and Nydam, 2006).  The sera from animals sampled post-partum were analyzed for 
NEFA, BHBA, and hemolysis (Stokol and Nydam, 2006).  Hemolysed samples were discarded. 
The reproductive information collected consisted of herd use of ovulation 
synchronization program and timed AI, voluntary waiting period (VWP), calving date, calving 
season, DIM at conception, and when applicable, culling date and pregnancy status at culling.  
Reproductive success was measured as pregnancy within 70 d post-individual herd VWP.  This 
classification was used to standardize the time at risk to get pregnant and to avoid penalizing 
cows from herds with longer VWP.  Pregnancy diagnosis was performed by the herd veterinarian 
by rectal palpation or ultrasound and recorded by herd personnel.  Calving season was 
dichotomized into 2 categories: warm months (May to September) and cool months (October to 
April).  Parity was dichotomized into 2 groups: parity 1 or ≥2.  Body condition score was 
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determined at time of blood sample collection (Ferguson et al., 1994) and dichotomized into 2 
groups: <3.75 or ≥3.75. 
Milk production information was collected as ME305 milk yield measured at 
approximately 120 DIM (incorporating 4 test-days) and was retrieved from DHIA or on-farm 
Dairy Comp 305 records. 
Statistical Analysis 
All data was stratified based on time of sample collection, pre- or post-partum.  Initially, 
heifers and cows were evaluated separately, but if the association between the covariates and the 
outcome of interest was similar they were grouped in the final analyses.  Reproduction and milk 
production were the 2 outcomes of interest and measured as conception within 70 d post-
individual herd VWP and ME305 milk yield (kg) assessed at 120 DIM, respectively. 
For both outcomes, the metabolites NEFA and BHBA were evaluated as the main 
categorical predic tors in 3 models: pre-partum NEFA; post-partum NEFA and BHBA; and 
BHBA alone.  Beta-hydroxybutyrate is easily measured in the field; therefore, its effect as a 
main predictor was modeled separately from NEFA. 
Reproduction 
Time from individual herd VWP until pregnancy was modeled using a semiparametric 
proportional hazards model (Cox, 1972) accounting for clustering of cows within herds with 
Proc Phreg (SAS Institute, 2004).  In addition to the main effects of NEFA and BHBA, the 
covariates BCS, parity, and ME305 milk were evaluated.  The ME305 milk data were 
dichotomized based on the median production of the 2 sampled cohorts.  The effect of an 
elevated metabolite concentration was evaluated by dichotomizing the metabolite concentration 
within the range of values identified as critical thresholds for prediction of diseases in Ospina et 
al., (2010).  The ranges were as follows: pre-partum NEFA, 0.27 to 0.37 mEq/L; post-partum 
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NEFA, 0.36 to 0.72 mEq/L; and BHBA, 7 to 12 mg/dL.  The dichotomized NEFA and BHBA 
concentrations   that resulted in the smallest chance of committing a type I error and had the 
largest estimate were kept in the final model. 
The Cox proportional hazards models allowed the use of information from animals   that 
did and did not become pregnant; however, animals   that were culled before the end of the VWP 
were excluded from the analysis.  Animals not pregnant by the end of the follow- up period were 
right censored.  The proportional hazards assumption was checked statistically by evaluating 
time-dependent covariates (Allison, 1995).  Noninformative censoring was evaluated with 
sensitivity analysis.  Kaplan-Meier estimator graphs (Proc Lifetest) of time to pregnancy within 
70 d post-VWP for animals with elevated metabolite levels were created (SAS Institute, 2004). 
Milk Production 
Mature-equivalent 305-d milk yield was modeled using a mixed effects model (Proc 
Mixed) with herd as a random effect in SAS (SAS Institute, 2004).  In addition to the main 
predictors (NEFA and BHBA), the covariates BCS, calving season, and when applicable, parity 
and the interaction between parity and the metabolite concentration were evaluated.  The effect 
of elevated NEFA and BHBA concentrations was evaluated by dichotomizing the concentrations 
within the range of critical values previously identified.  The dichotomized metabolite 
concentration   that resulted in the smallest chance of committing a type I error and largest 
estimate was kept in the final model. 
RESULTS 
Descriptive Data 
Ninety-one herds were included in the study, and the herd size ranged from 265 to 2,770 
with a mean of 827 lactating animals.  In total, 2,259 cows were used to evaluate reproductive 
performance, of which 1,164 were sampled pre-partum (37% heifers and 63% cows) and 1,095 
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were sampled post-partum (41% heifers and 59% cows).  In total, 2,290 animals were used to 
evaluate milk production, of which 1,183 were sampled pre-partum (36% heifers and 64% cows) 
and 1,107 were sampled post-partum (41% heifers and 59% cows). 
The median ME305 milk production measured at 120 DIM for heifers sampled pre-
partum was 12,572 kg and for those sampled post-partum was 12,550 kg.  The median milk 
production for cows sampled pre-partum and post-partum was 12,254 and 12,197 kg, 
respectively.  The VWP ranged from 40 to 75 d.  More than 95% of herds used ovulation 
synchronization programs.  The mean pregnancy rate was 19.6 (median 19.5) and ranged from 9 
to 32. 
Reproduction in the Pre-partum Cohort 
Heifers and cows were grouped in the final analyses because the associations between 
pre-partum NEFA concentrations and reproductive performance were similar.  In animals 
sampled pre-partum, and controlling for BCS, calving season, milk production, and parity, the 
effect of having a NEFA concentration ≥0.27 mEq/L resulted in 19% decreased risk (hazard ratio 
= 0.81) of conception within 70 d post-VWP (P = 0.01; Table 3.1).  In this model, parity was the 
only other significant covariate, where animals with parity ≥2 resulted in a 27% decreased risk of 
conception within 70 d post- VWP (P = 0.001; Table 3.1).  Figure 3.1 is a graph of the Kaplan-
Meier estimation of animals sampled pre-partum; animals with NEFA values ≥0.27 mEq/L took 
longer to get pregnant than animals with NEFA values <0.27 mEq/L (P = 0.03). 
Reproduction in the Post-partum Cohort 
Heifers and cows were grouped in the final analyses because the associations between 
post-partum NEFA and BHBA concentrations and reproductive performance were similar.  In 
animals sampled post-partum, and controlling for BCS, calving season, milk production, parity, 
and BHBA dichotomized at 10 mg/dL, the effect of having a NEFA value ≥0.72 mEq/L resulted 
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in a 16% decreased risk (hazard ratio = 0.84) of conception within 70 d post-VWP (P = 0.05; 
Table 3.2).  In this model, parity was the only other significant covariate where parity ≥2 resulted 
in a 19% decreased risk of conception within 70 d post-VWP (P = 0.01).  When BHBA was 
evaluated as the only main predictor (i.e., without NEFA in the model) and after controlling for 
BCS, calving season, and parity, animals with BHBA ≥10 mg/dL had a 13% decreased risk of 
conception (P = 0.1).  In this model, parity was the only significant covariate where parity ≥2 
resulted in a 20% decreased risk of conception within 70 d post-VWP (P = 0.01; Table 3.3). 
Milk Production in the Pre-partum Cohort 
Data from heifers and cows sampled pre-partum were combined in the final analysis 
because the association between pre-partum NEFA concentrations and milk production were 
similar for both parity groups.  After controlling for parity, BCS, calving season, and the 
interaction between NEFA and parity, a NEFA concentration ≥0.33 mEq/L in animals sampled 
pre-partum resulted in a decrease of 683 kg in ME305 milk (P =0.001).  Parity was the only other 
significant covariate (P = 0.01; Table 3.4). 
Milk Production in the Post-partum Cohort 
The final analyses were stratified by parity because the association between post-partum 
NEFA and BHBA concentrations and ME305 milk yield were different between heifers and 
cows.  In heifers, after controlling for BCS, calving season, and BHBA dichotomized at 10 
mg/dL, heifers with NEFA concentrations ≥0.57 mEq/L had increased ME305 milk yield of 488 
kg (P =0.02).  There were no other significant covariates in this model (Table 3.5).  In heifers 
sampled post-partum, when BHBA was evaluated as the main predictor, without NEFA in the 
model, and after controlling for calving season and BCS, heifers with BHBA ≥9 mg/dL had an 
increase of 403 kg more ME305 milk (P = 0.04; Table 3.6). 
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In cows sampled post-partum, after controlling for BCS and calving season, those with 
NEFA ≥0.72 mEq/L had a 647 kg decrease in ME305 milk (P = 0.001; Table 3.7).  No other 
covariates were significant in this model.  When BHBA was evaluated as the main predictor, 
without NEFA in the model, and after con trolling for BCS and calving season, those with 
BHBA ≥10 mg/dL had a 393 kg decrease in ME305 milk yield (P = 0.04; Table 3.8).  No other 
covariates were significant in this model.  
Table 3.1. Cox proportional hazards model for the effect of NEFA, covariates, and cows 
clustered within herds on d to conception within 70 d post VWP for animals sampled pre-partum 
(n=1,164) 
Variable Parameter estimate Standard error Hazard Ratio P 
NEFA1 -0.21 0.08 0.81 0.01 
BCS2 0.02 0.10 1.03 0.8 
Season3 -0.02 0.09 0.98 0.8 
Parity4 -0.31 0.09 0.73 0.001 
ME 3055 -0.03 0.09 0.97 0.6 
1NEFA: dichotomized < or ≥ 0.27 mEq/L. 
2BCS: dichotomized at < or ≥ 3.75.  
3Season: dichotomized into warm (May to September) versus cool months (October to April).  
4Parity: dichotomized into < or ≥ 2.  
5ME 305: dichotomized into < or ≥ median for animals sampled pre-partum. 
 
 
Table 3.2. Cox proportional hazards model for the effect of NEFA, BHBA, covariates, and cows 
clustered within herds on d to conception within 70 d post VWP for animals sampled postpartum 
(n=1,095) 
Variable Parameter estimate Standard error Hazard Ratio P 
NEFA1 -0.17 0.09 0.84 0.05 
BHBA2 -0.07 0.10 0.93 0.4 
BCS3 0.11 0.08 1.12 0.2 
Season4 0.12 0.09 1.13 0.2 
Parity5 -0.21 0.09 0.81 0.01 
ME 3056 0.06 0.08 1.06 0.5 
1NEFA dichotomized at < or ≥ 0.72 mEq/L. 
2BHBA: dichotomized at < or > 10mg/dL. 
3BCS: dichotomized at < or ≥ 3.75.  
4Season: dichotomized into two seasons; warm (May to September) versus cool (October to 
April).  
5Parity: dichotomized at < or ≥ 2.  
6ME 305: dichotomized at < or ≥ median for animals sampled postpartum. 
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Table 3.3. Cox proportional hazards model for the effect of BHBA, covariates and cows 
clustered within herds on d to conception within 70 d post VWP for animals sampled 
postpartum (n=1,095) 
Variable Parameter estimate Standard error Hazard Ratio P 
BHBA1 -0.14 0.10 0.87 0.1 
BCS2 0.09 0.08 1.11 0.3 
Season3 0.12 0.09 1.13 0.2 
Parity4 -0.23 0.09 0.80 0.01 
ME 3055 0.06 0.08 1.07 0.4 
1BHBA: dichotomized at < or ≥ 10mg/dL. 
2BCS: dichotomized at < or ≥ 3.75.  
3Season: dichotomized into two seasons; warm (May to September) versus cool (October to 
April).  
4Parity: dichotomized at < or ≥ 2.  
5ME 305: dichotomized at < or ≥ median for animals sampled postpartum. 
 
 
Table 3.4. Mixed model for the effect of NEFA, covariates, and herd as a random effect on milk 
production measured by 120 DIM ME 305 kg for animals sampled pre-partum (n=1,183) 
Variable Difference in ME milk yield (kg)  Standard Error P 
NEFA1 -683 180 0.0001 
BCS2 -9 130 0.9 
Season3 170 220 0.4 
Parity4 -556 225 0.01 
Parity*NEFA5 246 270 0.4 
1 NEFA: dichotomized at < or ≥ 0.33mEq/L. 
2 BCS: dichotomized at < or ≥ 3.75. 
3 Season: dichotomized into two seasons; warm (May to September) versus cool (October to 
April).  
4 Parity: dichotomized at < or ≥ 2.   
5  Interaction between parity and NEFA. 
 
Table 3.5. Mixed model for the effect of NEFA, BHBA, covariates, and herd as a random effect 
on milk production measured by 120 DIM ME 305 kg for heifers sampled postpartum (n=449) 
Variable Difference in ME milk yield (kg) Standard Error P 
NEFA1 488 203 0.02 
BHBA2 -143 238 0.5 
BCS3 -0.3 193 0.9 
Season4 340 273 0.2 
1 NEFA: dichotomized at < or ≥ 0.57mEq/L. 
2 BHBA: dichotomized at < or ≥ 10 mg/dL. 
3 BCS: dichotomized at < or ≥ 3.75. 
4 Season: dichotomized into two seasons; warm (May to September) versus cool (October to 
April).  
 
 
92 
 
 
Table 3.6. Mixed model for the effect of BHBA, covariates, and herd as a random effect on 
milk production measured by 120 DIM ME 305 kg for heifers sampled postpartum (n=449) 
Variable Difference in ME milk yield (kg) Standard Error P 
BHBA1 403 195 0.04 
BCS2 38 193 0.8 
Season3 270 273 0.3 
1 BHBA: dichotomized at < or ≥ 9 mg/dL. 
2 BCS: dichotomized at < or ≥ 3.75. 
3 Season: dichotomized into two seasons; warm (May to September) versus cool (October to 
April).  
 
 
Table 3.7. Mixed model for the effect of NEFA, BHBA, covariates, and herd as a random effect 
on milk production measured by 120 DIM ME 305 kg for cows sampled postpartum (n=658) 
Variable Difference in ME milk yield (kg) Standard Error P 
NEFA1 -647 195 0.001 
BHBA2 -165 205 0.4 
BCS3 -70 203 0.7 
Season4 270 242 0.3 
1 NEFA: dichotomized at < or ≥ 0.72mEq/L. 
2 BHBA: dichotomized at < or ≥ 10 mg/dL. 
3 BCS: dichotomized at < or ≥ 3.75. 
4 Season: dichotomized into two seasons; warm (May to September) versus cool (October to 
April).  
 
Table 3.8. Mixed model for the effect of BHBA, covariates, and herd as a random effect on milk 
production measured by 120 DIM ME 305 kg for cows sampled postpartum (n=658) 
Variable Difference in ME milk yield (kg) Standard Error P 
BHBA1 -393 195 0.04 
BCS2 -165 202 0.40 
Season3 335 247 0.20 
1 BHBA: dichotomized at < or ≥ 10 mg/dL. 
2 BCS: dichotomized at < or ≥ 3.75. 
3 Season: dichotomized into two seasons; warm (May to September) versus cool (October to 
April). 
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Figure 3.1. Graph of Kaplan-Meier estimator of time to pregnancy for animals with pre-partum 
non-esterified fatty acids (NEFA) ≥ 0.27 mEq/L or < 0.27 mEq/L (P = 0.03). 
 
 
DISCUSSION 
Reproduction 
Cows with excessive NEB (i.e., concentrations of pre- and post-partum NEFA and 
BHBA above the thresholds determined in this study) had a decreased risk of pregnancy within 
70 d post-VWP (Tables 3.1 to 3.3).   This observation is consistent with previous reports that 
NEB is detrimental to reproductive performance (Villa-Godoy et al., 1988; Wathes et al., 2007).    
Although elevated concentrations of both NEFA and BHBA resulted in decreased risk of 
conception, NEFA concentrations generally had a stronger association with reproductive 
performance than did BHBA.   When both post-partum NEFA and BHBA were in the same 
model, BHBA was not as strong a predictor as NEFA.  The strong association between NEFA 
concentrations and reproductive performance is likely because of the more direct physiological 
relationship between NEFA concentrations and NEB (Herdt, 2000).   The concentration of 
NEFA increases because of lipolysis, which is positively stimulated by glucagon.  Glucagon 
release is stimulated by hypoglycemia, a direct effect of NEB.   Although BHBA concentrations 
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are also related to NEB, they are regulated by several other factors including NEFA supply to the 
liver, activity of carnitine palmitoyltransferase (CPT-1), and intramitochondrial activity of 3-
hydroxy-3-methylglutaryl-CoA (HMG-CoA) synthase (Hegardt, 1999; Drackley et al., 2001). 
Reproductive performance was evaluated with time to event analysis.  Individual herd 
VWP was incorporated into the time to event analysis to create equal time at risk for pregnancy; 
thus, avoiding penalizing herds with longer VWP.   The VWP could be incorporated as a factor 
in the time to event analysis because over 95% of the study population used ovulation 
synchronization protocols and timed artificial insemination.  In this population, other commonly 
used measures of reproductive performance, such as time to first insemination or display of 
estrus, were not useful indicators because these events were either scheduled or not measured. 
Seventy day post-VWP was chosen as a measure of reproductive performance because 
we wanted to evaluate the effects of elevated NEFA and BHBA concentrations during the 
transition period on reproduction during this time frame.  In addition, conception during this time 
interval represents an optimal calving interval, such that loss associated with days open may be 
minimized (Schmidt, 1989; Meadows et al., 2005).  A potential limitation of this study was that 
reproductive performance was not followed until the end of lactation; however, given the scope 
of this project, extending the follow-up time may have introduced additional confounders and 
diluted the effect of NEFA and BHBA concentrations. 
In addition to NEFA or BHBA concentrations, several other covariates were examined to 
control for potential confounding: parity, BCS, calving season, and median ME305 milk 
production.  Of these covariates, parity was the only one that was significant in addition to the 
main effects of NEFA or BHBA.  Cows had a decreased risk of pregnancy compared with 
heifers.  This was expected because heifers usually have a higher conception risk than cows.  The 
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effect of BCS on reproductive performance was not significant in this analysis, as has been 
reported previously (Ruegg and Milton, 1995).  However, contrary to other reports (Oseni et al., 
2003; Huang et al., 2008), season was not significantly associated with reproductive 
performance.  Interestingly, milk production did not significantly affect reproductive 
performance (Hansen et al., 1983b; Leroy et al., 2008).  Although there has been controversy 
regarding the association between milk production and reproductive performance, it is not 
surprising that there was no significant association in the present study.  Several studies report   
that NEB as measured by NEFA or BHBA has a stronger association with reproductive 
performance than milk production (Reist et al., 2003; Walsh et al.,2007; Wathes et al., 2007).   It 
is important to note that NEFA NEFA concentrations generally increase closer to calving; 
therefore, studies that sample closer to calving may have higher cut-points associated with 
downstream outcomes (e.g., milk production, disease events, or re production) than those 
reported here, which included cows sampled as far as 2 wk pre-partum. 
In this study, although information on disease incidence (displaced abomasum, clinical 
ketosis, metritis, or retained placenta) was available for the animals, it was not included in the 
investigation of reproductive performance or milk production.   The metabolite concentrations 
used as main predictors in these models are correlated with the development of disease (Ospina 
et al., 2010) and, as such, would introduce multicollinearity if they were in the same model.    
Further, the study design employed a cross-sectional sampling strategy such as those typically 
used in field investigations or in monitoring (Oetzel, 2004).  In these scenarios, only information 
concurrently available would be used to predict reproductive performance or milk production.   
For example, information on parity and calving season could be incorporated easily, but 
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information on future development of diseases or serial measurement of NEFA or BHBA 
concentrations would not. 
Milk Production 
Milk production was estimated using ME305 milk yield measured at 120 DIM.  Mature-
equivalent 305-d milk yield was used in this study because it allows us to compare heifers and 
cows, and, with information from 4 test-days, ME305 is a precise estimate of total milk 
production (Quist et al.  , 2007).  Generally, the results of this study are similar to those of other 
reports; elevated concentrations of BHBA were associated with decreased milk production 
(Dohoo and Martin, 1984; Duffield et al., 2009).  In addition, we also investigated the 
association of NEFA with milk production and the effect was similar.  However, in this study, 
heifers sampled post- partum showed an inverse relationship; heifers with elevated metabolite 
levels (NEFA ≥0.57 mEq/L, BHBA ≥9 mg/dL) produced more ME305 milk compared with 
heifers with concentrations below these levels.  Duffield et al., (2009) also found a similar 
relationship, but did not distinguish between parities.  In   that study, cows ketotic in wk 2 post-
partum had lower first test milk yield, but had higher second and third test milk yields compared 
with their nonketotic counterparts.   Heifers find themselves in a unique physiological 
circumstance: they have to balance maintenance, growth, and milk production, and as a result 
may mobilize energy re- sources such as lipid more readily than cows.   This concept of 
homeorhesis may help explain our findings (Bauman and Currie, 1980).   
Although elevated concentrations of NEFA and BHBA were significantly associated with 
ME305 milk production, NEFA concentrations generally had a stronger association with milk 
production than did BHBA.   Pre-partum NEFA concentrations resulted in the lowest chance of 
committing a type I error (P = 0.0001).  When both post-partum NEFA and BHBA were in the 
same model, NEFA concentrations were so strongly associated with ME305 milk   that BHBA 
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was no longer a significant effect in the model.   The strong association between NEFA 
concentrations and milk production is likely because of the direct physiological relationship 
between NEFA concentrations and lipid mobilization.   
In addition to NEFA and BHBA concentrations, BCS, calving season, parity, and, when 
applicable, the interaction between parity and the metabolite concentration were examined.  In 
all groups, the single measure of BCS in the transition period was not a significant predictor of 
milk production.   Ruegg and Milton (1995) showed   that the change in BCS, and not the single 
measurement, was predictive of milk production, which may explain our result.  Mature-
equivalent 305-d milk yield incorporates season into the total calculation; therefore, it was 
unsurprising   that season was not a significant predictor of ME305 milk.  Parity was the only 
significant covariate in animals sampled pre-partum. This is likely because ME305 would be 
higher for heifers versus cows in progressive herds.  It is important to note that the interaction 
between parity and NEFA concentration was not significant, which means that although there 
was a difference based on parity, it was not dependent on whether the NEFA concentration was 
above or below the threshold used in this study.   
CONCLUSIONS 
The current analysis allowed the opportunity to ex amine the effect of elevated 
concentrations of pre- and post-partum NEFA and post-partum BHBA on reproduction and milk 
production at the cow level.  The NEFA and BHBA concentrations above which reproduction 
and production effects were most likely to occur were identified.  Generally, compared with 
animals with metabolite concentrations below the identified thresholds, animals with pre-partum 
NEFA ≥0.27 mEq/L, post-partum NEFA ≥0.72 mEq/L, and post-partum BHBA ≥10 mg/dL had 
a decreased risk of pregnancy within 70 d post-VWP.   Milk production was decreased in 
animals with pre-partum NEFA concentrations ≥0.33 mEq/L.  In heifers sampled post-partum, 
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there was an increase in milk production when post-partum NEFA was ≥0.57 mEq/L and BHBA 
≥9 mg/dL; however, in cows, milk production was decreased when post-partum NEFA and 
BHBA were ≥0.72 mEq/L and 10 mg/dL, respectively. 
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ABSTRACT 
The objectives were to: 1) identify the herd-alarm level for excessive negative energy balance, 
i.e. the proportion of sampled transition cows per herd with elevated pre-partum NEFA, post-
partum BHBA and NEFA concentrations that was associated with herd-level incidence of 
displaced abomasum (DA) or clinical ketosis (CK), pregnancy rate (PR) and milk production and 
2) describe the herd-level prevalence of this proportion. This was a prospective cohort study of 
60 free-stall, total mixed ration-fed (TMR) herds in the northeast USA. Two animal cohorts were 
assessed, those 14 to 2 d pre-partum and 3 to 14 d post-partum.Serum was analyzed from 
approximately 15 animals from each cohort for pre-partum NEFA and post-partum BHBA and 
NEFA. The herd-level effect of the proportion of animals with concentrations of NEFA or 
BHBA above a critical threshold was evaluated with a mixed effects model with herd as a 
random effect. The effect of more than 15% of sampled animals with pre-partum NEFA 
concentrations ≥ 0.27 mEq/L was associated with a 3.6% increase in DA and CK incidence, 
1.2% decrease in PR, and 282 kg decrease in average mature equivalent (ME 305) milk.If more 
than 15% of animals sampled during the post-partum had BHBA concentrations ≥ 10 to 12 
mg/dL, DA and CK incidence increased by 1.8% and PR decreased by 0.8%.ME 305 milk yield 
was stratified by parity such that if more than 20% of heifers had BHBA concentrations ≥ 12 
mg/dL ME 305 decreased by 534 kg and if more than 15% of cows had BHBA concentrations ≥ 
10 mg/dL ME 305 milk decreased by 358 kg.If more than 15% of animals sampled had post-
partum NEFA concentrations ≥ 0.70 mEq/L then DA and CK incidence increased by 1.7% and if 
NEFA was ≥ 0.60 mEq/L then PR decreased by 0.9%.ME 305 milk yield results were stratified 
by parity such that if more than 15% of sampled heifers had post-partum NEFA ≥ 0.60 mEq/L 
ME 305 milk decreased by 288 kg and if more than 15% of cows had NEFA ≥ 0.70 mEq/L ME 
305 milk decreased by 593 kg.The prevalence of herds above the herd alarm level, i.e. herds 
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having more than 15% of animals sampled with: pre-partum NEFA concentration ≥ 0.30 mEq/L 
was 75%; BHBA ≥ 12 mg/dL was 40%; and post-partum NEFA ≥ 0.70 mEq/L was 65%.This 
study showed that if a large enough proportion of cows had elevated metabolite concentrations 
there were detrimental herd-level effects, and further demonstrates that there is a high prevalence 
of herds with opportunity for improvement. 
Key words: herd alarm level, NEFA, BHBA 
INTRODUCTION 
 The transition from late gestation to early lactation is a critical period in a dairy cow’s life 
because failure to successfully overcome the negative energy balance (NEB) caused by the 
sudden increase in energy demand due to lactation and lagging dry matter intake (Drackley et al., 
2001) can increase the risk of detrimental health and reproductive outcomes (Herdt, 2000).At the 
cow level, elevated beta-hydroxybutyrate (BHBA) and non-esterified fatty acid (NEFA) 
concentrations have been used as markers of excessive NEB.Previous studies have shown that 
elevated concentrations of these metabolites are associated with increased risk of developing 
detrimental health (Cameron et al., 1998; LeBlanc et al., 2005; Ospina et al., accepted) 
reproductive (Walsh et al., 2007) and production outcomes (Dohoo and Martin, 1984; Duffield et 
al., 2009). 
 Recently, objective cow-level thresholds have been determined for increased BHBA  and 
NEFA concentrations that are associated with disease, reproductive and production outcomes 
(LeBlanc et al., 2005; Duffield et al., 2009; Ospina et al., accepted).This information allows the 
identification of individual cows at risk for these downstream outcomes based on their NEB 
status during the transition period.However, despite all of the NEB information available at the 
cow-level and its association with downstream outcomes, individual cow strategies for 
prevention of subclinical disease are still a challenge (Duffield, 2000).This is in part due to the 
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fact that changes associated with NEB adaptation can start as early as 6 wk pre-partum (Drackley 
et al., 2001).Efforts to improve NEB status should be implemented at the herd-level where 
decisions about nutritional management and other aspects of the environment and herd 
management that in turn affect pre- and post-partum groups of cattle can be addressed 
appropriately. 
 Unfortunately, information regarding the appropriate herd alarm levels, i.e. the proportion 
of sampled animals with elevated concentrations of NEFA and BHBA, have not been well 
defined (Oetzel, 2004).The objectives of this study were to: 1) identify the herd-alarm level for 
excessive NEB, i.e. the proportion of sampled animals with elevated NEFA and BHBA that was 
associated with herd-level changes in the following downstream outcomes: incidence of 
displaced abomasum (DA) and clinical ketosis (CK), pregnancy rate (PR), and milk production, 
measured as mature equivalent 305 (ME 305) milk and 2) Describe the distribution of the herd-
level prevalence of this proportion among herds enrolled in this study.    
MATERIALS AND METHODS 
Study population and study design 
 A prospective cohort study was conducted from a convenience sample of dairy herds in 
New York, Pennsylvania, and Vermont between January 2006 and July 2007; further details of 
this study can be found in Ospina et. al. (accepted).To be included in this study a herd must have 
1) had > 250 milking cows, 2) had free-stall housing, 3) fed a TMR-based diet, 4) participated in 
DHIA or used Dairy Comp 305 (Version 2009; Valley Ag Software, Tulare, CA) or both, and 5) 
had follow-up information on at least 10 animals from each cohort.  
 In each herd, two separate cohorts of approximately 15 healthy, transition animals were 
sampled cross-sectionally.To reflect common herd demographics, one-third of the animals 
sampled were primiparous.Animals 14 to 2 d pre-partum were selected to form the pre-partum 
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cohort and animals 3 to 14 d post-partum were selected to form the post-partum cohort.Healthy 
was defined as not being in the sick pen, not currently receiving any medical treatment, and not 
displaying sick cow signs based on the interpretation of the research staff.This cross-sectional 
sampling scheme was done in order to estimate the herd-level prevalence of animals with an 
elevated NEFA or BHBA concentration with 90% confidence. 10 ml of blood was collected with 
a plain red-top evacuated tube from each animal’s coccygeal vessel. The samples were handled 
according to recommendations by Stokol and Nydam (2005). 
 All samples were analyzed using an automated wet chemistry analyzer (Hitachi 917, 
Roche Diagnositics, Indianapolis, IN) at the Cornell University Animal Health Diagnostic 
Center.The sera from the pre-partum cohort were analyzed for NEFA (NEFA-C, Wako 
Chemicals USA, Inc., Richmond, VA;) and hemolysis while the sera from the post-partum 
cohort were analyzed for NEFA, BHBA (β-HB, Catachem Inc., Bridgeport, CT) and hemolysis 
(Stokol and Nydam, 2006).Hemolyzed samples were excluded from the analysis.  
 Three outcomes of interest were evaluated: incidence of DA or CK in sampled animals, 
herd PR, and the average ME 305 milk production from sampled animals.Cases of DA or CK 
within 30 DIM were recorded and for consistency of documentation, disease and case definitions 
were provided to farm personnel as in Ospina et. al. (accepted).Briefly, DA was defined as 
movement of the 4th compartment of the stomach to a location on the right (RDA) or left side 
(LDA) of the cow and detected by auscultating a “ping” sound with finger percussion.Often, this 
cow had an abrupt decrease in milk production and was off feed.Clinical ketosis was defined as a 
cow that was off-feed, had sudden weight loss, and decreased milk production, but had no other 
detectable signs of disease and was treated with dextrose, propylene glycol, and/or steroids 
(Duffield et al., 1999).The average PR of the two 21 d periods after individual farm voluntary 
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waiting period (VWP) was recorded from Dairy Comp 305 to evaluate early lactation herd 
reproductive performance.Pregnancy diagnosis was performed by the herd veterinarian by either 
manual palpation or ultrasound per rectum. ME 305 milk yield was measured at approximately 
120 DIM (incorporating 4 test days), and retrieved from DHIA or on-farm Dairy Comp 305 
records.  
Statistical analysis 
 In summary, the pre-partum and post-partum cohorts were analyzed separately; however, 
both cohorts analyzed three models with three continuous.The three outcomes were: 1) incidence 
of DA or CK or both, 2) herd PR and 3) ME 305 milk.In each model the herd-alarm level for 
pre-partum NEFA, post-partum BHBA, or post-partum NEFA were evaluated as categorical 
main effects with herd size as a continuous covariate.Herd size was divided by 100 so that a one 
unit change in the model was reflective of a change in herd size of 100 animals.Cows and heifers 
were grouped in the final analyses if the association between the metabolites and the outcome of 
interest was similar between the two groups.All statistical analyses were performed using SAS v. 
9.1 (SAS Institute, Inc., Cary, NC) and evaluated with a mixed effects models (Proc mixed) with 
herd as a random effect.        
Metabolite thresholds and proportion of sampled animals. 
The herd-alarm level consists of two numbers: 1) the metabolite (NEFA or BHBA) 
concentration threshold above which detrimental downstream outcomes are most likely to occur 
and 2) the proportion of animals with metabolite concentrations above this threshold that is 
associated with herd-level downstream outcomes. To establish the herd-alarm level both of these 
parameters were evaluated concurrently. The lowest metabolite concentration and smallest 
proportion that yielded the smallest chance of committing a type I error and had the largest 
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change in the outcome of interest (e.g. largest increase in disease incidence) was kept in the final 
model.     
 The metabolite concentrations were evaluated within the range identified as critical 
thresholds associated with individual-cow health effects by previous reports (Ospina et al., 
accepted; Duffield et al., 2009).According to these reports, the metabolite ranges were: pre-
partum NEFA 0.27 to 0.37 mEq/L; post-partum NEFA 0.36 to 0.72mEq/L; and BHBA 7 to 14 
mg/dL.   
 Within each herd, we determined the proportion of animals at or above the 
thresholds.25% of animals with elevated metabolite levels within each herd the initial proportion 
used to evaluate the association between the proportion of sampled animals with elevated 
metabolites and downstream outcomes.In order to increase the sensitivity of the herd-alarm level, 
the proportion of animals with elevated metabolite levels was lowered by 5% increments. 
Prevalence 
To identify the prevalence of herds above the herd-alarm levels most commonly 
associated with downstream outcomes, herds with more than 15% of sampled animals with 
elevated pre-partum NEFA concentrations ≥ 0.30 mEq/L, BHBA ≥ 12 mg/dL, and post-partum 
NEFA ≥ 0.70 mEq/L were counted.Bar charts with four categories (≤ 15, >15 to ≤ 25, > 25 to ≤ 
35, and > 35) for the proportion of animals with metabolites above the thresholds were created.  
RESULTS 
Descriptive data 
 60 herds met the inclusion criteria and from these herds 1672 cows were included in the 
analysis. In the pre-partum cohort there were 867 animals (37% heifers and 63% cows) and 805 
in the post-partum cohort (41% heifers and 59% cows).The number of milking cows per herd 
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ranged from 353 to 2770 with a mean of 950.The animals sampled had a mean incidence of DA 
or CK or both of 8.3%, an average herd PR of 19.7% and an average ME 305 milk of 12,487 kg.     
Multivariable analysis 
Pre-partum cohort- NEFA. 
The herd-alarm level for all outcomes (DA or CK, PR, and ME 305 milk) was defined as 
having more than 15% of animals sampled with pre-partum NEFA ≥ 0.27 mEq/L (Table 4.1). 
Heifers and cows were grouped in the analysis for all outcomes of interest because the results 
between the groups were similar.Herds above this alarm level, i.e. when more than 15% of the 
sampled animals had a pre-partum NEFA concentration ≥ 0.27 mEq/L, had a 3.6% increase in 
the incidence of DA or CK or both (P = 0.006), a 1.2% decrease in PR (P = 0.006), and a 
decrease of 285 kg ME 305 milk yield  (P = 0.002).Herd size was a significant covariate in the 
PR and milk production model (P < 0.0001), but not significant in the disease model (P = 
0.1).Results indicate that for each additional hundred cows on a farm, PR and ME 305 milk 
production decreased. 
Post-partum cohort- BHBA.  
Table 4.2 describes the herd alarm levels associated with post-partum BHBA 
concentrations and the outcomes of interest. The herd-alarm level for the incidence of DA or CK 
or both, and PR was defined as having more than 15% of sampled animals with BHBA ≥ 12 
mg/dL. Herds above the alarm-level, i.e. when more than 15% of the sampled animals had a 
BHBA concentration ≥ 12 mg/dL, had a 1.8% increase in the incidence of DA or CK or both (P 
= 0.03), and a 0.8% decrease in PR (P = 0.03).The results for ME 305 milk were stratified by 
parity because the herd-alarm level between heifers and cows was different.The ME 305 milk 
yield herd-alarm level for heifers (n = 335) was defined as having more than 20% of sampled 
heifers with BHBA ≥ 12 mg/dL, and the herd-alarm level for cows (n = 470) was defined as 
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having more than 15% of sampled cows with BHBA ≥ 10 mg/dL.Heifers in herds above the 
alarm-level had a 534 kg decrease in ME 305 milk yield (P = 0.0002), and cows in herds above 
the alarm-level had a 358 kg decrease in ME 305 milk yield (P = 0.0004).Herd size was a 
significant predictor (P < 0.0001) of all outcomes except the incidence of DA or CK or both (P = 
0.8).Results indicate that for each additional hundred cows on a farm, PR and average ME 305 
milk production decreased. 
Post-partum cohort- NEFA. 
Table 4.3 describes the herd alarm levels associated with post-partum NEFA 
concentrations and the outcomes of interest. The herd-alarm level for the incidence of DA or CK 
or both was defined as having more than 15% of sampled animals with post-partum NEFA 
concentrations ≥ 0.70 mEq/L.Herds above this alarm level had a 1.7% increase incidence of DA 
or CK or both (P = 0.04).The herd-alarm level for the PR was defined as having more than 15% 
of animals with NEFA concentrations ≥ 0.60 mEq/L (P = 0.05).Herds above this alarm level had 
a 0.9% decrease in PR.The results for ME 305 milk were stratified by parity because the herd-
alarm level between heifers and cows was different.If more than 15% of the heifers (n = 335) 
sampled had post-partum NEFA ≥ 0.60 mEq/L then ME 305 decreased by 288 kg (P = 0.07).If 
more than 15% of the cows (n = 470) sampled had post-partum NEFA concentrations ≥ 0.70 
mEq/L then ME 305 decreased by 593 kg (P < 0.0001).Herd size was included as a continuous 
covariate in all models and was significantly associated (P < 0.0001) with all outcomes except 
for DA or CK (P = 0.9).Results indicate that for each additional hundred cows on a farm, PR and 
average ME 305 milk production decreased. 
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Prevalence   
From the 60 herds in the study, the prevalence of herds with more than 15% of sampled 
animals above the metabolite threshold was: 75% with pre-partum NEFA ≥ 0.30 mEq/L, 40% 
with BHBA ≥ 12 mg/dL, and 65% with post-partum NEFA ≥ 0.70 mEq/L (Figures 4.1 – 4.3). 
 
 
 
 
 
 
 
Table 4.1. Herd-level effect of elevated pre-partum NEFA concentrations on disease, pregnancy 
rate and ME 305 milk.  
 
I. Effect on disease1 if more than 15% of animals sampled with NEFA concentration ≥ 0.27 
mEq/L  
Variable Change in percent of disease Standard error P 
NEFA 3.6  1.3 0.006 
Herd size2  - 0.2 0.1 0.1 
 
II.Effect on pregnancy rate3 if more than 15% of animals sampled with NEFA concentration ≥ 
0.27 mEq/L  
Variable Change in pregnancy rate (%) Standard error P 
NEFA - 1.2 0.4 0.006 
Herd size2 - 0.3 0.04 < 0.0001 
 
III. Effect on average ME 305 milk if more than 15% of animals sampled with pre-partum 
NEFA concentration ≥ 0.27 mEq/L.  
Variable Change in ME 305 milk (kg) Standard error P 
NEFA - 282 91 0.002 
Herd size2  - 47 7.2 < 0.0001 
1 Disease is measured as the proportion of sampled animals that developed a displaced 
abomasum or clinical ketosis or both.  
2 Herd size: 1 unit change = 100 additional cows  
3 Herd pregnancy rate: average of the two 21-day periods post herd voluntary waiting period.  
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Table 4.2. Herd-level effect of elevated BHBA concentrations on disease, pregnancy rate and 
ME 305 milk. 
 
I.Effect on disease1 if more than 15% of animals sampled post-partum with BHBA 
concentration ≥ 12 mg/dL.  
Variable Change in percent of 
disease 
Standard error P 
BHBA 1.8 0.8 0.03 
Herd size2 0.02 0.08 0.8 
 
II. Effect on herd pregnancy rate3  if more than 15% of animals sampled post-partum with 
BHBA concentration ≥ 12 mg/dL on. 
Variable Change in pregnancy rate (%) Standard error P 
BHBA - 0.8 0.4 0.03 
Herd size2  - 0.3 0.04 < 0.0001 
 
III. Effect on average ME 305 milk in heifers if more than 20% of heifers sampled post-partum 
with BHBA concentration ≥ 12 mg/dL.  
Variable Change in ME 305 milk (kg) Standard error P 
BHBA - 534  141 0.0002 
Herd size2  - 64 12 < 0.0001 
 
IV. Effect on average ME 305 milk in cows if more than 15% of cows sampled post-partum 
with BHBA concentration ≥ 10 mg/dL.  
Variable Change in ME 305 milk (kg) Standard error P 
BHBA -358 99 0.0004 
Herd size2  -53 10 < 0.0001 
1 Disease is measured as the proportion of sampled animals that developed displaced abomasum, 
or clinical ketosis or both.  
2 Herd size: 1 unit change = 100 additional cows  
3 Herd pregnancy rate: average of the two 21-day periods post herd voluntary waiting period. 
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Table 4.3. Herd-level effect of elevated post-partum NEFA concentrations on disease, 
pregnancy rate and ME 305 milk. 
 
I.Effect on disease1 if more than 15% of animals sampled with post-partum NEFA 
concentration ≥ 0.70 mEq/L  
Variable Change in percent of disease Standard error P 
NEFA 1.7 0.8 0.04 
Herd size2  -0.003 0.07 0.9 
 
II. Effect on herd pregnancy rate3 if more than 15% of animals sampled with post-
partum NEFA concentration ≥ 0.60 mEq/L  
Variable Change in pregnancy rate (%) Standard error P 
NEFA -0.9 0.5 0.05 
Herd size2 -0.3 0.04 < 0.0001 
 
III. Effect on average ME 305 milk in heifers if more than 15% of heifers sampled 
post-partum with NEFA concentration ≥ 0.60 mEq/L  
Variable Change in ME 305 milk (kg) Standard error P 
NEFA -288 159 0.07 
Herd size2 -66 13 < 0.0001 
 
IV. Effect on average ME 305 milk in cows if more than 15% of cows sampled post-
partum with NEFA concentration ≥ 0.70 mEq/L  
Variable Change in ME 305 milk (kg) Standard error P 
NEFA - 593 107 < 0.0001 
Herd size2 - 56 10 < 0.0001 
1 Disease is measured as the proportion of sampled animals that developed displaced 
abomasum or clinical ketosis or both. 
2 Herd size: 1 unit change = 100 additional cows  
3 Herd pregnancy rate: average of the two 21-day periods post herd voluntary waiting 
period. 
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Figure 4.1. The prevalence of herds with more than 15% of sampled animals with  
pre-partum Non-esterified fatty acids (NEFA) concentration ≥ 0.30 mEq/L. 
 
 
Figure 4.2. The prevalence of herds with more than 15% of sampled animals with  
beta-hydroxybutyrate (BHBA) concentration ≥ 12 mg/dL. 
 
 
 
Figure 4.3. The prevalence of herds with more than 15% of sampled animals with  
post-partum Non-esterified fatty acids (NEFA) concentration ≥ 0.70 mEq/L. 
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DISCUSSION 
Several studies have investigated the association between individual transition animals 
with elevated NEFA or BHBA concentrations and detrimental downstream outcomes (Cameron 
et al., 1998; Duffield et al., 2009; Ospina et al., accepted), however herd-level effects of having 
an excessive proportion of animals with elevated NEFA or BHBA concentrations have not been 
well defined (Oetzel, 2004).This study defines the herd-alarm level for excessive NEB.The herd- 
alarm is the proportion of sampled transition cows per herd with elevated pre-partum NEFA, 
post-partum BHBA and NEFA concentrations that was associated with detrimental herd-level 
downstream outcomes.The outcomes assessed here were incidence of DA or CK or both, PR and 
ME 305 milk production.Generally, the results of this herd-level study are in agreement with 
previous individual cow studies; elevated NEFA or BHBA were associated with detrimental 
health, reproductive and milk production outcomes (Duffield et al., 2009; Ospina et al., 
accepted). 
The herd-alarm level for excessive NEB, i.e., the proportion of sampled animals with 
elevated metabolite (NEFA or BHBA) concentrations that were associated with herd-level 
outcomes was 15%, except when sampling heifers for BHBA with milk production as the 
outcome where the proportion was 20%. These were the smallest proportions that yielded the 
largest change in the outcome and the smallest chance of committing a type I error.The smallest 
proportion was chosen in order to increase the sensitivity of the test i.e. minimize the false 
negatives.The herd-alarm level for heifers may have been larger than it was for cows due to 
potential biological differences.Compared to cows, heifers have to balance maintenance, milk 
production as well as growth.As a result heifers may be more capable of managing mobilized 
energy resources than cows, thus more tolerant of elevated BHBA concentrations before 
negative outcomes are measurable.     
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Within each cohort, the thresholds for metabolite concentrations associated with the 
outcomes of interest were similar: 0.27 mEq/L for pre-partum NEFA; 10 or 12 mg/dL for 
BHBA, and 0.60 or 0.70 mEq/L for post-partum NEFA.The small difference in the BHBA 
concentration associated with effects on milk production is most likely due to a difference in 
sample size and population; cows and heifers were stratified in the analysis of milk 
production.As previously mentioned, it is not surprising that heifers would have a higher 
concentration of BHBA when compared to cows because they need to balance maintenance, milk 
production in addition to growth and as such may be more capable of using higher sub-clinical 
levels of ketones before negative effects are seen.The post-partum NEFA concentration was 0.60 
mEq/L for both milk production in heifers and PR and 0.70 mEq/L for both milk production in 
cows and disease.The difference in NEFA concentration between heifers and cows in the milk 
production model can be explained by the fact that these are different populations.In addition, the 
smaller sample size of heifers in the milk production model may make it difficult to see a smaller 
difference between the two groups (herds above the alarm level versus those that are 
not).Although the probability of saying that there is a difference when there really is no 
difference in PR is 5%, a post-partum NEFA concentration of 0.60 mEq/L may reflect that the 
reproductive system may be more sensitive to elevated NEFA concentrations in the transition 
period than the mechanism that increases the risk for a DA or CK. 
To identify whether a herd is above the herd-alarm level and at increased risk for 
negative downstream outcomes, the proportion of animals with elevated NEFA, BHBA or both 
can be measured.For herd-level testing a representative sample of adequate size is necessary.It is 
important to note that the desired confidence in the estimate of the proportion plays a larger role 
in sample size calculations than herd size.For example, to be 90% confident that the sample is 
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representative of the herd, with an assumed prevalence of 15% of animals with elevated 
metabolite concentrations, at least 15 animals at risk would need to be sampled.However, if 12 
animals were sampled, in a herd with the same assumed prevalence, the confidence that the 
sample is representative of the herd is reduced to 75%.     
One of the limitations of this study is that in some herds, information on fewer than 15 
animals was available.The implication of this is that the confidence that the sample represents 
the true herd-level prevalence is decreased.In addition, when evaluating the effects on milk 
production, the groups were stratified by parity because the herd-alarm level for each group was 
different, further decreasing our sample size per herd. However the herd-alarm level still had a 
strong association with the outcomes of interest.  
All outcomes of interest, incidence of DA or CK, herd PR, and ME 305 milk yield, were 
analyzed as continuous outcomes.Although pregnancy at the individual cow-level represents a 
dichotomous outcome, the herd PR can be evaluated as a continuous outcome.At the herd-level 
PR is represented with a binomial distribution which can be approximated to the normal 
distribution when the sample size is large (Casella and Berger, 1990).By approximating the 
binomial distribution to the normal, herd-level PR can be evaluated as a continuous outcome.In 
addition, to ensure that the cohorts of animals sampled in the transition period were represented 
in the PR, the animals were followed forward in time and the average of two 21 d periods post 
individual herd VWP were used.  
Herd size was also evaluated as a continuous covariate. The effect of increasing the herd 
size by 100 cows was significantly associated with PR and ME 305 milk production, but not with 
DA or CK incidence.In Table 4.3 for example, after controlling for post-partum NEFA 
concentrations, the effect of increasing herd size by 100 cows did not significantly affect (P = 
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0.9) disease incidence, but for each additional 100 cows on a farm, PR decreased by 0.3 (P < 
0.0001).  
Although there has been considerable focus on the study of NEB in the transition period 
(Drackley, 1999), high producing herds with good reproductive performance such as the ones 
studied here still had 40% to 75% of herds above the herd-alarm level. This demonstrates that 
although several herds were capable of benefiting from being below the herd-alarm level, there is 
still room for improvement.Recognizing herds at risk for increased disease incidence, decreased 
PR, and decreased milk production based on the effects of elevated NEFA or BHBA 
concentrations during the transition period may help herds focus on improving energy 
balance.Herds that choose to focus on herd-level factors for improving negative energy balance 
at the individual cow level may do so by focusing on nutritional management, diet, comfort, 
social adaptation and access to feed which may be the best methods of minimizing the lagging 
DMI during the transition period which is one of the major factors associated with NEB 
(Drackley et al., 2001). 
CONCLUSION 
 The current study offers herd-level analysis of the transition period based on the 
identification of both the NEFA and BHBA concentration threshold and the proportion of 
sampled animals with elevated metabolite thresholds that would mostly likely result in 
detrimental herd-level outcomes.Compared to herds with a low proportion of sampled animals 
with elevated NEFA or BHBA concentrations, herds with a high proportion of sampled animals 
with elevated metabolite concentrations had a higher incidence of DA and CK, lower PR and 
decreased ME 305 milk production.These herd-level effects were most likely to occur if 
metabolite concentration thresholds were: pre-partum NEFA ≥ 0.27 mEq/L, and post-partum 
BHBA ≥ 10 or 12 mg/dL and NEFA between 0.60 or 0.70 mEq/L.The proportion of animals 
118 
 
with NEFA or BHBA concentrations above the aforementioned thresholds that was associated 
with herd-level effects ranged from 15 to 20%.These herd-alarm levels may prove useful because 
generally between 40 to 75% of the herds sampled had more than 15% of animals sampled with 
NEFA or BHBA concentrations above the thresholds. 
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ABSTRACT 
The objectives were (1) to explain why the risk ratio (RR) is an appropriate measure of 
association when the outcome of interest is dichotomous (e.g., displaced abomasum or no 
displaced abomasum) in both cohort studies and randomized trials; and (2) to outline an 
applied method for estimating the RR using currently available software.Interest in the 
association between multiple risk factors and a yes or no outcome is very common in the dairy 
industry; historically, logistic regression, which reports odds ratios (OR), was the method 
available in common statistical packages to evaluate this kind of association.However, the OR 
can overestimate the magnitude of the response in cohort studies and randomized trials 
when the outcome frequency is large.In addition, the interpretation of odds is not intuitive; 
fortunately, recent advances in statistical software have allowed the estimation of the 
RR.Because SAS software (SAS Institute Inc., Cary, NC) is commonly used to analyze data, 
this technical note outlines the basic programming code that may be used to estimate the 
RR from raw data.Example data from a prospective cohort study was used to compare the OR 
and RR of developing a displaced abomasum or ketosis or metritis based on multiple 
predictors, their interaction, and a random effect (e.g., herd). 
Key words: risk ratio, odds ratio, Poisson, SAS software 
TECHNICAL NOTE 
Multivariable analysis; that is, evaluating the association, between multiple predictor 
variables such as main effects, covariates, and potential confounders with an outcome of interest, 
is common in dairy science research.This kind of analysis with a yes or no outcome (e.g., 
mastitis or no mastitis) has become more common but estimating the magnitude of the effect 
has been limited to 2 × 2 tables, ordinary least square (OLS) linear regression, OLS with an 
arc sine transformation, or logistic regression. 
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Although odds ratios (OR) can be estimated in any study with a yes or no outcome, 
risk ratios (RR) can only be estimated in studies where probabilities are measured 
directly; that is, cohort studies and randomized trials.The calculation of an OR and an RR 
and the algebraic relationship between them is shown for a general 2 × 2 table in Table A5.1 
of the Appendix.Although both measures of association can be estimated this way, when 
models contain several covariates and interaction terms, this approach is limiting and 
laborious. 
Although OLS linear regression can be used for analysis of data with several covariates, 
interaction terms, and a dichotomous outcome, several restrictions and assumptions are 
violated when the outcome is dichotomous (Dohoo et al., 2003) and the probability of success 
is <0.1 or >0.9 (Cox, 1970).The most severe consequence results from the violation of the 
homoscedasticity assumption.This violation can lead to inefficient estimates of coefficients 
and biased standard error estimates, which result in biased test statistics (Allison, 2001). 
An alternative approach to multivariable modeling of positive dichotomous 
outcomes has been logistic regression, which is based on the logit-transformation and 
maximum likelihood estimation.This transformation replaces the probability of a positive 
dichotomous outcome with the log odds, and re-establishes the linear link between this and 
the predictor variables. 
A search of the Journal of Dairy Science online through April 6, 2011, revealed that 
the first article to discuss the use of logistic regression for the analysis of a dichotomous 
outcome dates to 1987 (Curtis et al.,1987).Since then, 370 articles published in the Journal 
of Dairy Science have used the exact phrase “logistic regression” in the title, abstract, or 
text.The OR was frequently used because it is the estimable measure of association in some 
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study designs (i.e., case-control studies) or because estimating a more appropriate measure of 
association such as the RR was not readily feasible with commercially available statistical 
packages.Although the OR and not the RR was estimated, instead of reporting the odds, the 
results were sometimes misinterpreted as RR and incorrect phrases such as “more likely” or 
“risk” were used to describe the association between the risk factor(s) and the outcome of 
interest. 
Two problems are associated with estimating the OR in study designs where the RR 
can be estimated: (1) the OR can overestimate the true effect as the outcome becomes 
more common, and (2) interpretation of the OR is not intuitive (Holcomb et al., 2001) 
because, unlike the RR, the OR does not directly measure effects on probability.The objectives 
of this study are to explain why the RR is the preferred measure of association when the 
outcome of interest is dichotomous in both cohort studies and randomized trials and to 
outline an applied method for estimating the RR using SAS version 9.2 (SAS Institute Inc., 
Cary, NC). 
Objective 1: Preference of RR to OR in Certain 
Study Designs 
Although estimating the OR is not incorrect, in study designs where the RR can be 
estimated it is considered the more appropriate measure of association (Greenland, 1987; 
Spiegelman and Hertzmark, 2005), because it provides estimates of probabilities 
directly.The OR can overestimate the true effect when interpreted as a probability in studies 
where the frequency is large, and the interpretation of odds is not as intuitive as 
probabilities.To demonstrate that the OR can overestimate the RR as the incidence of the 
outcome increases, simple example calculations of OR versus RR are provided in Table 
A5.2 of the Appendix.The incidence ranges from 5 to 30%.The example with 30% incidence 
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could reflect that seen in a study of mastitis and demonstrates the potential 
overestimation of the effect when an OR is estimated instead of an RR. 
The RR can be calculated from cohort studies and cross-sectional studies as well as 
randomized trials.These are subsets of 2 general study designs, observational and 
experimental, respectively.When an experiment is not feasible, observational studies are 
used to evaluate whether an association exists between a risk factor and an outcome of 
interest.These studies can be divided into 3 groups: cross-sectional, cohort, and case-control.In 
a cross-sectional study, both exposure and the outcome of interest are determined 
simultaneously; therefore, information is lacking about whether the exposure preceded the 
outcome.In a cohort study, subjects are selected based on whether they have been exposed to 
the risk factor or not and then followed to determine whether they develop the outcome of 
interest; thus, outcome probabilities can be estimated directly.Conversely, in a case-control 
study, subjects are selected based on whether they have the outcome of interest (case) or not 
(control) and then information on whether they were exposed to the risk factor is collected 
retrospectively.This type of selection is used to investigate rare outcomes; however, it results 
in a predetermined ratio of cases to controls and only the ratio of the odds can be estimated. 
In situations where an experiment is feasible, a randomized trial is considered the best 
method to determine causality between a risk factor (e.g., treatment) and the outcome of 
interest.Randomization reduces potential confounding and more control exists over exposure 
to the risk factor of interest.For example, to determine whether treatment with propylene 
glycol (exposure) to transition cows reduces the risk of the development of ketosis 
(outcome), cows can be randomly assigned to receive propylene glycol or placebo, and then 
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the RR or OR of developing ketosis given administration of propylene glycol can be 
estimated. 
In the preceding example, both the OR and the RR could be estimated.However, the 
OR reports the ratio of the odds that the cow will develop ketosis, given that she was treated 
with propylene glycol, to the odds that the cow will develop ketosis, given that she was not 
treated, whereas the RR reports the ratio of the probability that the cow will develop 
ketosis, following exposure, to the probability that the cow will develop ketosis when not 
exposed.Because this was a randomized trial and the RR was estimable, the OR serves only 
as a potential overapproximation of the RR. 
Objective 2: Calculating the RR with Poisson Regression 
In light of some of the concerns with the use of the OR in cohort studies (Greenland, 
1987) and randomized trials, several methods have been proposed to estimate the RR.The 
use of a log link with a binary outcome appears to be a good choice because it can calculate 
the RR directly.However, this method can have issues with convergence because the 
estimated probabilities are not confined to the allowable parameter space between 0 and 1 
(McNutt et al., 2003).Although several techniques to address the convergence issues have 
been proposed (Zocchetti et al., 1995), they can be complex and difficult to 
implement.Other authors (Zhang and Yu, 1998; Kleinman and Norton, 2009) advocated the 
use of logistic regression to estimate the RR through additional calculations, using the fact 
that the odds is equal to [P/(1 − P)], where P = probability, as a way to avoid the 
parameter space limitations and thus, avoid convergence issues; however, this can lead to 
biased estimators (McNutt et al., 2003; Zou, 2004).Poisson regression has its own 
limitations, namely, that it might provide conservative results (Zou, 2004); that is, the 
confidence interval will be wider.It can have convergence issues due to parameter space 
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concerns as in the log binomial model, but this is rare in practice and the model will not 
yield results if it does happen.Poisson regression has several advantages such as, when used 
with binary data, the estimates are unbiased, which means that Poisson regression will 
produce consistent estimations of the relative risk (Lumley et al., 2006).Additionally, when 
used in cohort studies, it can account for different times at risk (Zou, 2004), a function 
that cannot be supported by the log-binomial model. 
The use of Poisson regression to calculate RR has been advocated by several authors 
(Frome and Checkoway, 1985; McNutt et al., 2003; Zou, 2004).Although Poisson regression 
is commonly associated with the evaluation of count data, it can also be used for binary 
data.The only model restrictions are as follows: the dependent variable must be a 
nonnegative integer and it must have a Poisson distribution conditional on the values of 
the explanatory variables (Allison, 2001).Data from a prospective cohort study of 1,318 
Holsteins in 100 herds (Ospina et al., 2010) were used to demonstrate the method for 
calculating the RR with PROC GENMOD using SAS.In this study, approximately 15 cows 
in the postpartum period (3 to 14 DIM) were sampled per herd.The sampling consisted of 
drawing blood and measuring a single serum BHBA concentration from healthy cows and 
heifers.These animals were followed to 30 DIM, and within this timeframe, 3 disease 
outcomes were documented: (1) displaced abomasum, (2) ketosis, or (3) metritis.The 
dichotomous outcome of interest was the presence or absence of any of the 3 diseases.The 
predictor variables were (1) exposure to an elevated concentration of BHBA between 3 to 
14 DIM (main effect), (2) parity (potential confounder), (3) the interaction between BHBA 
and parity, and (4) herd as a random effect.The concentration at which BHBA was 
considered elevated was 10 mg/dL, which was previously determined by receiver operator 
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characteristic curve analysis (Ospina et al., 2010).Parity was dichotomized as 1 or ≥2. The 
SAS code without and with the interaction term will be demonstrated and discussed in the next 
two sections. 
Evaluation without interaction term 
The RR (without interaction term) can be estimated with PROC GENMOD, as follows: 
proc genmod descending data = work.BHBAstudy; 
class herd BHBA Parity; 
model disease = BHBA Parity / link = log dist = Poisson pscale type3; 
repeated subject = herd/ type = exch ;  
estimate ‘BHBA’ BHBA 1 −1/ exp;  
estimate ‘Parity’ Parity 1 −1/exp; 
run; 
 
The first line of the SAS code tells the system what procedure to run, how to read the 
data, and where to find the data.The procedure is GENMOD and, in this case, the data can be 
found in a work file titled “BHBAstudy.” The word “descending” relates to how the outcome 
data are read.By default, when evaluating a dichotomous outcome, the program will model 
the probability of the smallest outcome variable.In most cases, the outcome variable is coded 
as 0 or 1, where 0 means that the outcome of interest (event) did not occur, and 1 means 
that the outcome of interest (event) did occur.Research interest usually lies in evaluating 
the risk of developing the outcome of interest, so adding the “descending” option to the first 
line tells the program to model the probability of the largest outcome variable. 
The second line of the code is the class statement.This tells the program that the 
variables “herd,” “BHBA,” and “parity” are categorical variables.Any class variables, including 
those in the repeated statement should be included in this line. 
The third line is the model statement.The model statement defines the equation that 
will be examined.In this case, the association between the outcome of interest (occurrence of 
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any of the 3 diseases) and the predictor variables (main effects, exposure to an elevated 
concentration of BHBA; potential confounders, parity) will be evaluated.To run Poisson 
regression using PROC GENMOD, the log link and Poisson distribution must be specified 
after a forward slash (/) in the model statement. 
A major assumption of the Poisson distribution is that the variance is equal to the 
mean (Agresti, 2007); however, unless all factors are controlled for in a model, this is rarely 
the case and overdispersion usually occurs.Overdispersion does not bias the coefficients, but 
it can underestimate the standard errors (Allison, 2001).Correcting the standard errors for 
overdispersion is done by adding the “pscale” option to the model statement.Under the 
“pscale” option, each standard error is multiplied by the square root of the Pearson chi-
squared statistic for testing goodness of fit, and divided by its degrees of freedom.The 
“pscale” option is preferred to the “dscale” option due to the theory of quasi-likelihood 
estimation (McCullagh and Nelder, 1989).The “type3” option offers the opportunity to 
examine the results without regard to the order in which the terms are specified in the model 
statement and analyses are based on single degree of freedom.Although these score 
statistics evaluate the same hypothesis as the Z-statistics in the generalized estimating 
equation (GEE) parameter estimates, the score statistics usually report more conservative 
P-values (Stokes et al., 2000).Reporting these P-values should be considered in studies with 
small sample sizes. 
The fourth line of code is the repeated statement.In PROC GENMOD, a class 
variable (e.g., herd) can be used to cluster individual samples (e.g., cows).It is reasonable to 
suspect that more similarities will exist among cows within the same herd versus those 
between herds (McDermott et al., 1994a,b).In addition to the measured characteristics 
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included in the model, many unmeasured characteristics in the herd will likely have an 
effect on the probability of whether a cow gets any of the 3 diseases, for example.These 
intra-herd similarities can be taken into account by incorporating the repeated-measures 
statement and specifying the structure of the correlation matrix as “exch.” Choosing the 
“exch” option specifies a single correlation that applies to any pair of animals within each 
cluster (Allison,2001), meaning that within each herd, the probability of developing the 
outcome of interest should be similar given levels of the risk factors, but this probability 
can be different between herds.In addition, this modification can be used to correctly 
estimate the standard error for the RR (Zou, 2004). 
The fifth and sixth lines of code are the estimate statements.These statements 
serve 2 functions: allow contrasts and exponentiate the estimate from the base e (“exp” 
option after the forward slash).This exponentiation facilitates evaluation of the RR because 
it no longer needs to be done by hand.It is important to examine the estimate statement 
closely as this will determine the interpretation of the results.The “1 −1” in this statement 
compares the BHBA concentration ≥10 mg/dL to BHBA <10 mg/dL (the reference level) 
and estimates the RR with a 95% CI based on the Wald statistic.It is important to note 
that SAS will choose the predictor variable with the largest numerical value as the 
reference level.Estimate statements can be written for any variable in the model.The SAS 
output generated from running this code can be found in Table 5.1. 
As shown in Table 5.1, the RR for developing any of the 3 diseases given that BHBA 
was ≥10 mg/dL was 4.5, meaning that cows with BHBA concentration ≥10 mg/dL were 
4.5 times more likely to develop a displaced abomasum, clinical ketosis, or metritis than 
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cows with BHBA <10 mg/dL.However, the OR estimated using PROC LOGISTIC was a 
slight overestimation at 5.1.The interpretation of the OR is that a cow with BHBA 
≥10 mg/dL has 5.1 greater odds of developing any of the 3 diseases than a cow with BHBA <10 
mg/dL.Note that this is not the likelihood or probability of having the event, but specifically 
the odds. 
Evaluation with interaction term 
The RR (with interaction term) can be calculated with PROC GENMOD, as follows: 
proc genmod descending data = work.BHBAstudy; 
class herd BHBA Parity ; 
model Disease = BHBA Parity BHBA*Parity / link = log dist = Poisson pscale 
type3;  
repeated subject = herd/ type = exch;  
lsmeans BHBA10 * Parity / pdiff cl exp;  
run; 
 
Evaluating a 1-way interaction is useful for testing the hypothesis that the 
relationship between one predictor variable and the outcome depends on the level of the 
second predictor variable.In this example, the interaction between BHBA and parity was 
evaluated to see if the effect of elevated BHBA on the development of any of the 3 diseases 
was different if parity = 1 or if parity ≥2, or if the effect of parity on the development of 
disease was different if BHBA was ≥10 mg/dL or <10 mg/dL. 
A few key differences can be seen in this code compared with the code without the 
interaction term.The first major difference can be found in the third line, the model 
statement.The model statement now contains an interaction term, “BHBA * Parity.” 
Interaction terms are incorporated into the model by taking the individual variables and 
adding an asterisk between them; that is, var 1 * var 2 (e.g., BHBA * Parity).Because the 
BHBA example consisted of categorical variables, a discussion of continuous variables is not 
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included; however, the interpretation of interactions with categorical variables is similar to 
that of continuous variables. 
The “lsmeans” statement with “pdiff,” “cl,” and “exp” options is the second major 
difference in this code.This “lsmeans” statement allows the examination of all the 
permutations of categorical variables in the interaction terms, and one “lsmeans” statement 
should be written for each interaction term in the model.The output generated from this 
statement will give the RR for all of the permutations and the “cl” option provides 95% 
confidence limits.Although 95% is standard, this can be changed by suggesting a different α; 
to do so, add “alpha = #” after the “cl” term.This will also work under the “estimate” 
statement in the previous example.Generally, when an interaction term is included in a 
model statement there is no longer one single estimate that determines the RR of the 
outcome based on the terms included in the interaction term; it is now dependent on the 
level of the second variable. 
The SAS output generated from running the model statement can be found in 
Tables 5.2, 5 . 3, and 5.4.Table 5.2 contains the information from running the model 
statement, the output from the LSMEANS statement is in Table 5.3, and the output from 
the PDIFF, CL, and exp options are found in Table 5.4.The inclusion of the interaction 
term in the model statement means that the single estimate listed in Table 5.2 of 1.28 for 
BHBA can no longer solely be used to estimate the RR of developing any of the 3 
diseases, because the effect of BHBA on disease risk depends on the level of parity.Also, 
in Table 5.2, the estimate of 0.60 for the interaction term (BHBA * Parity) represents the 
change in the estimate of the main effect (BHBA) when the other variable (parity) changes 
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by 1 level.The P-value associated with the interaction term at this level of analysis is 
evaluating whether the interaction has a statistically significant effect on the outcome. 
The information in Table 5.3 offers the opportunity to examine the risks of 
developing the outcome (any of the 3 diseases).See Table A5.3 in the Appendix for the 
mathematical formulation used to evaluate the interaction term.To calculate the RR, the 
information in Table 5.4 or the calculations in the Appendix are necessary.The 
information in Table A5.3 shows how the numbers in Table 5.3 were estimated; that is, 
where they came from, and shows simple calculations of the RR when an interaction term 
is included.Table 5 . 4 allows independent evaluation of each of the permutations of the 
interactions and tests whether the difference is significantly different from zero.The column 
labeled “exponentiated” has the RR for each of the permutations of the interaction 
term.The confidence limits for the RR are estimated in Table 5.4.The Appendix has sample 
calculations of RR of interest.Because a log link was used, the natural log is taken on 
both sides of the equation to evaluate the estimates.In this example, the RR for the 
development of disease given that BHBA was ≥ 10 mg/dL was 6.6 when parity was =1, 
and 3.6 when parity was ≥ 2. 
Because incorporation of an interaction term can make interpretation of the model more 
complex, the decision to include an interaction term in a model should not be taken lightly.As 
previously stated, Table 5.4 allows the evaluation of all permutations of the interaction model 
and in this case, no significant difference (P = 0.17, 0.27) was found when permutations were 
compared across parity levels and BHBA levels were held constant.This information along with 
the large likelihood that the difference based on parity was due to chance (P = 0.27) may result 
in deciding to remove parity and the interaction term from the model. 
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Poisson regression was used to estimate the RR.Poisson regression analysis is appropriate 
when the response variable is a count or a rate and the results can be interpreted as a rate ratio 
(Frome and Checkoway, 1985).Counts represent the number of events that occurred over an 
observed period; however, if that period is similar between all subjects, then the rate ratio 
approximates the RR.This relationship can be seen with the following equations of a hypothetical 
example when each cow contributes 1 cow-week of time at risk: 
𝑅𝑎𝑡𝑒 𝑟𝑎𝑡𝑖𝑜 =  𝐼𝑛𝑐𝑖𝑑𝑒𝑛𝑐𝑒 𝑟𝑎𝑡𝑒 𝑖𝑛 𝑡ℎ𝑒 𝑒𝑥𝑝𝑜𝑠𝑒𝑑
𝐼𝑛𝑐𝑖𝑑𝑒𝑛𝑐𝑒 𝑟𝑎𝑡𝑒 𝑖𝑛 𝑡ℎ𝑒 𝑢𝑛𝑒𝑥𝑝𝑜𝑠𝑒𝑑 =  3 𝑐𝑎𝑠𝑒𝑠 10 𝑐𝑜𝑤 − 𝑤𝑒𝑒𝑘𝑠�1 𝑐𝑎𝑠𝑒 10 𝑐𝑜𝑤 − 𝑤𝑒𝑒𝑘𝑠�  
 
𝑅𝑖𝑠𝑘 𝑟𝑎𝑡𝑖𝑜 =  𝐼𝑛𝑐𝑖𝑑𝑒𝑛𝑐𝑒 𝑟𝑖𝑠𝑘 𝑖𝑛 𝑡ℎ𝑒 𝑒𝑥𝑝𝑜𝑠𝑒𝑑
𝐼𝑛𝑐𝑖𝑑𝑒𝑛𝑐𝑒 𝑟𝑖𝑠𝑘 𝑖𝑛 𝑡ℎ𝑒 𝑢𝑛𝑒𝑥𝑝𝑜𝑠𝑒𝑑 =  3 𝑐𝑎𝑠𝑒𝑠 10 𝑒𝑥𝑝𝑜𝑠𝑒𝑑 𝑐𝑜𝑤𝑠�1 𝑐𝑎𝑠𝑒 10 𝑒𝑥𝑝𝑜𝑠𝑒𝑑 𝑐𝑜𝑤𝑠�   
 
It should be noted that if some counts correspond to different periods at risk than others, 
then the rate at which the events occur must be included in the model (Stokes et al., 2000; Zou, 
2004).This is done by including an “offset” term after the forward slash in the model statement 
(e.g., offset = time at risk).The natural log of the time at risk should be calculated to include this 
information in the model.In the current BHBA study, all animals were at risk for similar periods, 
so the offset term was not included (i.e., was equal to 1). 
Interpretation of an RR is intuitive.Many studies that estimate an OR interpret it 
incorrectly as an RR (Holcomb et al., 2001).It is important to note that when the incidence of the 
outcome is low (e.g., ≤ 5%), the RR and OR are very similar in magnitude.Yet, the difference 
between the estimate of the OR versus the RR becomes larger and therefore more of a concern as 
the incidence becomes greater (Appendix Tables A5.1 and A5.2).The RR reports the likelihood 
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that the outcome of interest will happen, given a certain level of the risk factor, and is based on 
the idea that the sample for this calculation is representative of the true population.This SAS 
code will estimate the RR and therefore, eliminates the need to estimate the OR in cohort studies 
and randomized trials. 
Table 5.1. SAS output for estimating the risk ratio (RR) of developing a displaced abomasum, 
ketosis, or metritis with Poisson regression using PROC GENMOD. 
Analysis Of GEE Parameter Estimates 
Empirical Standard Error Estimates 
 Parameter Estimate Standard 
Error  
95% Confidence 
Limits 
Z Pr > |Z| 
 Intercept -3.0450 0.2097 -3.4560 -2.6341 -14.52 <0.0001 
 BHBA1 1 1.4946 0.1828 1.1363 1.8529 8.18 <0.0001 
 BHBA 0 0.0000 0.0000 0.0000 0.0000 . . 
 Parity2 1 0.0350 0.1738 -0.3057 0.3757 0.2 0.8406 
 Parity 2 0.0000 0.0000 0.0000 0.0000 . . 
 
Score Statistics for Type 3 GEE analysis 
 
Source DF Chi-Square Pr > ChiSq 
BHBA 1 29.32 <0.0001 
Parity 1 0.04 0.8437 
 
Contrast Estimate Results 
 
Label 
 
Estimate 
 
Standard 
Error 
 
Alpha 
 
95% Confidence 
Limits 
 
Chi-
Square 
 
Pr>ChiSq 
BHBA 1.4946 0.1828 0.05 1.1363 1.8529 66.84 <0.0001 
Exp(BHBA) 4.45763 0.8149 0.05 3.1152 6.3785   
PARITY 0.0350 0.1738 0.05 -0.3057 0.3757 0.04 0.8406 
Exp (Parity) 1.03564 0.1800 0.05 0.7366 1.4560   
1 β-hydroxybutyrate (BHBA) concentration dichotomized: 10 if < 10 mg/dL (reference level) and 1 if ≥ 10 mg/dL.  
2 Parity dichotomized: 1 if parity =1 and 2 if ≥ 2 (reference level). 
3 Risk ratio of developing any of the three diseases if BHBA concentration was ≥ 10 mg/dL. 
4 Risk ratio of developing any of the three diseases if Parity was =1. 
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Table 5.2. Output from SAS software (SAS Institute Inc., Cary, NC) for estimating the risk ratio 
(RR) with Poisson regression using PROC GENMOD to evaluate the model1 with an interaction term of 
BHBA and Parity. 
 
Analysis of GEE Parameter Estimates 
Empirical Standard error Estimates 
Parameter Estimate Standard 
Error 
95 % Confidence Limits Pr > |Z| 
Intercept 
BHBA2 
Parity3 
BHBA * Parity 
-2.9157 
1.2844 
-0.3265 
0.6008 
0.2092 
0.2072 
0.2953 
0.3447 
-3.3257 
0.8783 
-0.9053 
-0.0749 
-2.5057 
1.6905 
0.2523 
1.2765 
<0.0001 
<0.0001 
0.2689 
0.0814 
 
1 The model: disease outcomes (displaced abomasum, or ketosis, or metritis ) = BHBA2 + Parity3 + 
BHBA * Parity + cows clustered within herds  
2 β-hydroxybutyrate (BHBA) concentration dichotomized: 10 if < 10 mg/dL (reference level) and 1 
if ≥ 10 mg/dL  
3 Parity dichotomized: 1 if parity =1 and 2 if ≥ 2 (reference level). 
 
 
 
Table 5.3. Abbreviated SAS software (SAS Institute Inc., Cary, NC) output generated from LSMEANS 
statement1.  
 
BHBA * Parity Least Square Means 
 
BHBA1 Parity2 
 
Estimate Standard Error Z value Pr > |Z| 
1 1 -1.3569 0.1658 -8.18 <0.0001 
1 2 -1.6313 0.1501 -10.86 <0.0001 
0 1 -3.2422 0.2672 -12.14 <0.0001 
0 2 -2.9157 0.2092 -13.94 <0.0001 
1 The following columns were omitted: alpha, lower and upper confidence limits for estimate, 
exponentiated estimate, and 95% CL of exponentiated estimate. 
 
 
Table 5.4. Abbreviated SAS software (SAS Institute Inc., Cary, NC) output obtained from the 
‘PDIFF CL Exp’ options in the LSMEANS statement1.  
 
Differences of Least Square Means 
BHBA Parity BHBA Parity Estimate Standard 
Error 
P2 Exponen.3 
lower 
Exponen.4 
upper 
Exponentiated5 
1 1 1 2 0.2743 0.1979 0.1658 0.8926 1.9392 1.3156 
1 1 0 1 1.8852 0.3009 <0.0001 3.6526 11.8817 6.5878 
1 1 0 2 1.5587 0.2418 <0.0001 2.9588 7.6348 4.7529 
1 2 0 1 1.6109 0.2879 <0.0001 2.8514 8.7932 5.0073 
1 2 0 2 1.2844 0.2072 <0.0001 2.4069 5.4223 3.6126 
0 1 0 2 -0.3265 0.2953 0.2689 0.4044 1.2870 0.7215 
1 The following columns were omitted: Z value, alpha, lower and upper confidence limits for 
estimate.   
2 P-value: for the hypothesis that the difference between the two levels within the interaction 
is different from zero. 
3 95% confidence limits of exponentiated estimate, i.e., 95% Confidence limits for risk ratio for 
specific interaction. 
4 The risk ratio for each permutation of the interaction term. 
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APPENDIX 
 
In a case control study (based on the 2 X 2 table in Table A1), the odds ratio (OR) is calculated 
as follows: 
 
𝑂𝑑𝑑𝑠 𝑅𝑎𝑡𝑖𝑜 = 𝑂𝑅 = 𝑖𝑛 𝑎 𝑐𝑎𝑠𝑒 𝑐𝑜𝑛𝑡𝑟𝑜𝑙 𝑠𝑡𝑢𝑑𝑦(𝑏𝑎𝑠𝑒𝑑 𝑜𝑛 2 𝑏𝑦 2 𝑡𝑎𝑏𝑙𝑒 𝑎𝑏𝑜𝑣𝑒)                      = 𝑜𝑑𝑑𝑠 𝑡ℎ𝑎𝑡 𝑎 𝑐𝑎𝑠𝑒 𝑤𝑎𝑠 𝑒𝑥𝑝𝑜𝑠𝑒𝑑 
𝑜𝑑𝑑𝑠 𝑡ℎ𝑎𝑡 𝑎 𝑐𝑜𝑛𝑡𝑟𝑜𝑙 𝑤𝑎𝑠 𝑒𝑥𝑝𝑜𝑠𝑒𝑑   = 𝑎 𝑏�𝑐 𝑑�   =   𝑎𝑑𝑏𝑐  
Table A5.1. An example of a 2 x 2 table.  
 Outcome 
(Positive)1 
Outcome 
(Negative)2 
Total 
Exposed to Risk factor a  b  a + b 
Not- exposed to Risk factor  c  d  c + d 
Total a + c b + d a+b+c+d 
1 Positive outcome = individual developed the outcome of interest 
2 Negative outcome = individual did not develop the outcome of interest 
 
 
In a cohort study or randomized trial, the risk ratio (RR) is calculated as follows: 
 
𝑅𝑖𝑠𝑘 𝑅𝑎𝑡𝑖𝑜 = 𝑅𝑅 = 𝑖𝑛 𝑎 𝑐𝑜ℎ𝑜𝑟𝑡 𝑠𝑡𝑢𝑑𝑦 𝑜𝑟 𝑟𝑎𝑛𝑑𝑜𝑚𝑖𝑧𝑒𝑑 𝑡𝑟𝑖𝑎𝑙 
=  𝑖𝑛𝑐𝑖𝑑𝑒𝑛𝑐𝑒 𝑜𝑓 𝑜𝑢𝑡𝑐𝑜𝑚𝑒 𝑖𝑛 𝑡ℎ𝑜𝑠𝑒 𝑒𝑥𝑝𝑜𝑠𝑒𝑑 𝑡𝑜 𝑟𝑖𝑠𝑘 𝑓𝑎𝑐𝑡𝑜𝑟
𝑖𝑛𝑐𝑖𝑑𝑒𝑛𝑐𝑒 𝑜𝑓 𝑜𝑢𝑡𝑐𝑜𝑚𝑒 𝑖𝑛 𝑡ℎ𝑜𝑠𝑒 𝑛𝑜𝑡 𝑒𝑥𝑝𝑜𝑠𝑒𝑑 𝑡𝑜 𝑟𝑖𝑠𝑘 𝑓𝑎𝑐𝑡𝑜𝑟 =  𝑎𝑎 + 𝑏𝑐
𝑐 + 𝑑    Thus (𝑤ℎ𝑒𝑛 𝑎 𝑎𝑛𝑑 𝑐 𝑎𝑟𝑒 𝑟𝑒𝑙𝑎𝑡𝑖𝑣𝑒𝑙𝑦 𝑠𝑚𝑎𝑙𝑙), the RR approximates the OR as follows:      = 𝑎𝑎 + 𝑏𝑐
𝑐 + 𝑑     = 𝑎 (𝑐 + 𝑑)𝑐 (𝑎 + 𝑏)  ~ 𝑎𝑑𝑏𝑐    
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Table A5.2. Five Sample calculations of OR and RR1 
Example 1. Incidence of the outcome was 2.5% and χ2 P-value testing a difference between the 
exposed and not exposed group was 0.002.The OR and RR were similar (4.1 vs. 4, respectively). 
Incidence 
2.5% 
Outcome 
(+) 
Outcome 
(-) 
Total Results 
Exposed (+) 20 480 500 OR 4.1 
Exposed (-) 5 495 500 RR 4.0 
Total 25 975 1000 χ2 P = 0.002 
Example 2. Incidence of the outcome was 5% and χ2 P-value testing a difference between the 
exposed and not exposed group was < 0.001.The OR was larger than RR (4.3 vs. 4, respectively).  
Incidence 
5% 
Outcome 
(+) 
Outcome 
(-) 
Total Results 
Exposed (+) 40 460 500 OR 4.3 
Exposed (-) 10 490 500 RR 4.0 
Total 50 950 1000 χ2 P < 0.001 
Example 3. Incidence of outcome was 10% and χ2 P-value testing a difference between the exposed 
and not exposed group was < 0.001.The OR was larger than RR (4.6 vs. 4, respectively).  
Incidence 
10% 
Outcome 
(+) 
Outcome 
(-) 
Total Results 
Exposed (+) 80 420 500 OR 4.6 
Exposed (-) 20 480 500 RR 4.0 
Total 100 900 1000 χ2 P < 0.001 
Example 4. Incidence of outcome was 15 % and χ2 P-value testing a difference between the exposed 
and not exposed group was < 0.001.The OR was larger than RR (5 vs. 4, respectively).  
Incidence 
15% 
Outcome 
(+) 
Outcome 
(-) 
Total Results 
Exposed (+) 120 380 500 OR 5.0 
Exposed (-) 30 470 500 RR 4.0 
Total 150 850 1000 χ2 P < 0.001 
Example 5. Incidence of outcome was 30 % and χ2 P-value testing a difference between the exposed 
and not exposed group was < 0.001.The OR was larger than RR (6.8 vs. 4, respectively). 
Incidence 
30% 
Outcome 
(+) 
Outcome 
(-) 
Total Results 
Exposed (+) 240 260 500 OR 6.8 
Exposed (-) 60 440 500 RR 4 
Total 300 700 1000 χ2 P < 0.001 
1 Examples have outcome incidences that range from 2.5 to 30%.This is used to illustrate the point 
that the discrepancy between OR and RR gets larger as the incidence increases. 
 
  
141 
 
 
Table A5.3. Calculations of the risk of developing any of the 3 diseases and example calculations 
of RR with the incorporation of an interaction term. 
Model:  Y1 = B0 + B1 * BHBA2 (0,1) + B2  * Parity3 (0,1) + B34 * BHBA (0,1) *Parity (0,1) 
 
Y= B0 B1 * BHBA B2  * 
Parity  
B34 * BHBA*Parity Risk of 
Y5 
 
Given 
 
 
DA, 
CK or 
MET 
- 2.9 + 1.3 * 1 - 0.33 * 1 +0.60 * 1 * 1 e -1.3 BHBA ≥ 10mg/dL 
Parity = 1 
 
- 2.9 + 1.3 *1 - 0.33 * 0 +0.60 * 1 * 0 e -1.6 BHBA ≥ 10mg/dL 
Parity  ≥ 2 
 
- 2.9 + 1.3 * 0 - 0.33 * 1 +0.60 * 0 * 1 e -3.2 BHBA < 10mg/dL 
Parity = 1 
 
- 2.9 + 1.3 * 0 - 0.33 * 0 +0.60 * 0 * 0 e -2.9 BHBA < 10mg/dL 
Parity ≥ 2 
1 Y=  any combination of the three diseases = displaced abomasum (DA), clinical ketosis (CK), metritis (MET).  
2 β-hydroxybutyrate (BHBA) concentration dichotomized: 0 if < 10mg/dL (reference level) and 1 if ≥ 10 mg/dL.  
3 Parity dichotomized: 1 if parity =1 and 0 if ≥ 2 (reference level).  
4 B3 = 0.6, this is the change in the estimate of the main effect (BHBA) when the other variable (parity) changes by 
one level. 
5 The exponent calculated here, is the estimate in the column ‘estimate’ in Table 2A. 
 
Based on the information in Table A5.3, the following are examples of how the risk ratio 
(reported as “Exponentiated” in Table 5.4)  were derived: 
 
Sample calculations of risk ratios.  
   Risk 
Ratio 
 
 = 𝑒𝐵0+𝐵1(1)+𝐵2(1)+𝐵3 (1∗1) 
𝑒𝐵0 +𝐵1(0)+𝐵2(1)+𝐵3(0∗1)  
 = 𝑒𝐵1(1)+𝐵3(1) 
𝑒0+0
 
 = 𝑒1.28+0.6 
𝑒0 = 1   𝑒1.88 =6.6 The risk ratio of developing any of the 3 diseases when BHBA 
was > 10mg/dL and 
parity =1. 
 
 = 𝑒𝐵0+𝐵1(1)+𝐵2(0)+𝐵3 (1∗0) 
𝑒𝐵0 +𝐵1(0)+𝐵2(0)+𝐵3(0∗0)  
 = 𝑒𝐵1(1)+0+0
𝑒0+0+0
 
 = 𝑒1.28 
𝑒0 = 1  𝑒1.28 =3.6 The risk ratio of developing any of the 3 diseases when BHBA 
was > 10mg/dL and 
parity ≥ 2. 
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ABSTRACT 
The objectives of this study were to compare the negative energy balance (NEB) status of 
a herd based on individual samples versus pooled samples using beta-hydroxybutyrate (BHBA) 
concentrations; to estimate the herd-level sensitivity (HSe) and herd-level specificity (HSp) 
based on simulated individual animal sampling (varying sample size, underlying herd-level 
prevalence of elevated BHBA, and test sensitivity and specificity); and to estimate the herd 
predictive value positive (HPV+) and herd predictive value negative (HPV-) under the same 
simulation. 
Based on previous reports, the concentration of BHBA above which animals were 
considered at risk for excessive NEB was ≥ 12mg/dL and if more than 15% of the animals tested 
per herd had BHBA concentrations above this, then the herd was considered at increased risk.  
Twelve animal samples from 12 herds were evaluated both individually and the samples 
were pooled to compare the sensitivity and specificity of a pooled herd sample versus analyzing 
the proportion of individual samples which had BHBA concentrations ≥ 12 mg/dL.The kappa 
statistic was 0.13 (95% Confidence Interval CI: -0.08 to 0.33), McNemar’s p-value was 0.008 
and sensitivity and specificity of the pooled samples were 30 (95% CI: 7 to 65%) and 100 (95% 
CI: 19 to 100), respectively.  
Using a test with 0.96 sensitivity and 0.98 specificity, while varying the underlying 
within-herd true prevalence from 0 to 40% and the between-herd true prevalence also from 0 to 
40%, the HSe, HSp, HPV+, and HPV- values were estimated.Additionally, four different tests 
with varying sensitivities (96, 90, 88, and 78) and specificities (98, 86, 90, 96) were compared in 
two simulations, one with the underlying within and between herd true prevalence at 20% and 
the second with these prevalence parameters at 40%. 
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Pooled samples had a very low sensitivity, thus a large number of false negatives thereby 
increasing the potential for missing opportunities for improvement.It is recommended to evaluate 
samples individually by analyzing the proportion of animals with elevated BHBA 
concentrations. Although the underlying true prevalence of the condition being evaluated will 
affect the herd-level parameters, it is recommended to test 15 animals to maximize the HPV- and 
20 animals to maximize the HPV+.If more than 15% (≥ 2/15 or ≥3/20) of the animals sampled 
had BHBA ≥ 12 mg/dL, the herd is considered at risk for the negative outcomes associated with 
excessive NEB.  
Key words: herd alarm level, pooling test, BHBA  
INTRODUCTION 
Excessive negative energy balance (NEB), identified by increased levels of circulating 
non-esterified fatty acids (NEFA) and β-hydroxybutyrate (BHBA), during the transition period 
has been associated with increased disease (Ospina et al., 2010a) and decreased reproductive and 
milk production performance at both the individual animal (Duffield et al., 2009; Ospina et al., 
2010c; Chapinal et al., 2011)  and herd-level (Ospina et al., 2010b).Although much information 
has been gained from research focused on the effects of excessive NEB on individual animals; 
most management strategies intended to correct NEB are best implemented at the group or herd-
level.The ability to classify a herd as having excessive NEB, i.e., above the herd alarm level, can 
help detect opportunities for improvement. 
A recent study (Ospina et al., 2010b) identified the herd alarm level as having more than 
15% of sampled transition animals with BHBA concentrations ≥ 12 mg/dL.Herds above this 
alarm level had higher displaced abomasa (DA) and clinical ketosis (CK) incidence, decreased 
pregnancy rate (PR), and decreased milk production.The accuracy of this herd-based test 
depends primarily on the underlying true prevalence of the disease being monitored, individual 
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test sensitivity and individual test specificity; however, herd-level parameters such as herd-level 
sensitivity (HSe), herd-level specificity (HSp), herd-level predictive value positive (HPV+), and 
herd-level predictive value negative (HPV-) should also be evaluated. The HSe is the probability 
of having a herd test positive when it really does have excessive NEB, while the HSp is the 
probability of having a herd test negative when it really does not have excessive NEB. The 
HPV+ estimates the probability that a positive test came from a positive herd, conversely, the 
HPV – determines the probability that a negative test came from a negative herd.  
In order to correctly evaluate NEB at the herd-level, appropriate sample collection is 
critical, but it may be difficult to decide when to sample cows, how many cows to sample, and 
whether it is possible to pool the samples.These questions are of particular importance because 
the test results will be used to monitor progress and consequently affect management decisions at 
the herd-level.The objectives of this study are to: 1) to compare the NEB status of a herd based 
on individual samples versus pooled samples using BHBA concentrations from data collected 
from Ospina et al., (2010a), 2) estimate the HSe and HSp based on simulated individual animal 
sampling (varying sample size, underlying herd-level prevalence of elevated BHBA, and test 
sensitivity and specificity), and 3) estimate the HPV+ and HPV- under the same simulation. 
Because larger farms (>600 milking cows) will have animals at risk on a weekly basis, the 
frequency of sampling will also be discussed.        
MATERIALS AND METHODS 
Pooled samples 
Herds from a prospective cohort study (Ospina et al., 2010a) with a minimum of 12 
samples in the post-partum cohort were used in the analysis which compared individual versus 
pooled samples.During the study, herds were visited once and blood was sampled from 12 to 15 
healthy animals 3 to 14 DIM.Serum samples from this study were collected, handled and stored 
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according to sample handling recommendations (Stokol and Nydam, 2005; Stokol and Nydam, 
2006).The sera were analyzed for NEFA (NEFA-C, Wako Chemicals USA, Inc., Richmond, 
VA) and BHBA (β-HB, Catachem Inc., Bridegeport, CT) at the Cornell University Animal 
Health Diagnostic Center.  
To ensure that the herds included in the pooling analysis represented the range of 
metabolite concentrations, the eligible herds were stratified into quartiles based on mean post-
partum NEFA concentration.The arithmetic means and quartiles of the post-partum NEFA 
concentrations were calculated using commercial software (SAS v. 9.1, SAS Institute Inc., Cary, 
NC).The quartiles for post-partum NEFA were: < 0.42 mEq/L; ≥ 0.42 and < 0.57 mEq/L; ≥ 0.57 
and < 0.73 mEq/L; and ≥ 0.73 mEq/L.Three herds with post-partum NEFA means within each 
quartile were randomly selected with a ranuni seed for the analysis and resulted in a total of 12 
herds.From these 12 herds, 12 individual animal samples were also randomly selected using 
simple random sampling without replacement. The selected individual serum samples were 
thawed at room temperature for four hours and pooled herd samples were created with 200 μL 
aliquots from each individual sample.  
Based on previous reports (Ospina et al., 2010b), herds were defined as having excessive 
NEB if the proportion of individual samples with a metabolite concentration above the threshold 
was more than 15 % (≥ 2 animals from 12).The metabolite threshold for BHBA was ≥12 
mg/dL.To assess whether a herd had excessive NEB based on the pooled sample, the 
concentration of the pooled sample was compared to the metabolite threshold of ≥12 
mg/dL.Herds with pooled sample concentrations ≥12 mg/dL were considered to have excessive 
NEB.   
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McNemar’s p-value, Kappa statistic, sensitivity and specificity analysis were done to 
compare between individual and the pooled tests using SAS v. 9.2 (SAS Institute, Inc., Cary, 
NC).McNemar’s p-value evaluates bias between the two proportions and the Kappa statistic 
evaluates the agreement (beyond chance) between the two tests (Dohoo et al., 2003a; Dohoo et 
al., 2003b).Sensitivity and specificity analysis compared the pooled test to the individual tests 
and were calculated using Med Calc version 9.5.2.0 (Schoonjans, 2008).  
Individual tests- simulation analysis 
At the herd-level, the HSe and HSp are affected by the true prevalence (TP) of the 
condition of interest, the number of animals tested, the critical threshold used to decide whether 
the herd is positive (herd alarm level), and the sensitivity and specificity of the test used.The 
sensitivity and specificity used for this part of the analysis were: 0.96 and 0.98, 
respectively.However, given that there are various tests used to measure ketones each with 
differing sensitivities and specificities, the effect on HSe, HSp, HPV+ and HPV- were evaluated 
given the following test sensitivities and specificities: 0.96 and 0.98; 0.90 and 0.86; 0.88 and 
0.90; and 0.78 and 0.96 while keeping the within and between herd true prevalence at 20% and 
repeating the analysis with these prevalence parameters at 40%. 
Formulas presented by Martin et al., (1992) were used to estimate the HSe and HSp 
given: various permutations of different levels of TP (0 to 40%) and number of animals tested 
(10 to 25), all based on a 15% positive critical threshold.These calculations were done assuming 
no sampling variability, i.e., the sample prevalence is equivalent to the herd prevalence. 
The HSe is the probability of getting equal to or more than the critical threshold number 
of animals expected with BHBA concentrations ≥ 12 mg/dL, given that the herd is truly 
positive.The critical threshold used to determine whether a herd was positive was 15% or as 
close as possible considering that animals are whole numbers, so for example when the sample 
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size was 10, 15, 20 or 25, the cut-points were 2, 2, 3, and 4, respectively.The HSp is the 
probability of getting no positive tests in a herd with 0 true prevalence of animals with BHBA ≥ 
12 mg/dL. 
The herd-level predictive value positive (HPV+) and herd-level predictive value negative 
(HPV-) were estimated using the standard formulae for predictive values (Martin et al., 1992; 
Ospina et al., 2010b).The HPV + determines the probability that a positive herd test actually 
comes from a positive herd.The HPV – determines the probability that a negative herd test 
actually comes from a negative herd. These values are calculated based on HSe, HSp, and the 
true prevalence of infected herds; this is the pre-test probability that a herd is positive.The 
underlying TP of infected herds is estimated to be around 40% based on work presented by 
(Ospina et al., 2010b), however, the HPV+ and HPV- were evaluated on a range starting with a 
conservative estimation of 10% and up to 40% pre-test probability of being positive.   
RESULTS 
Pooled samples 
The proportion of the twelve herds with excessive NEB based on individual BHBA tests 
was 0.8, and the proportion of herds with excessive NEB based on pooled BHBA samples was 
0.3.The McNemar’s p-value was 0.008 and the kappa statistics was 0.13 (95% CI: -0.08 to 
0.33).The sensitivity and specificity of the pooled BHBA test when compared to the individual 
tests was 30 (95% CI: 7 to 65%) and 100 (95% CI: 19 to 100), respectively. 
Individual tests- simulation analysis   
In the simulation study, when the test sensitivity and specificity were held constant at 
0.96 and 0.98, respectively, the HSe varied based on underlying true prevalence and sample size 
(Figure 6.1).Although HSe increases as within herd TP increases, it is at its highest when the 
sample size is 15. This is because HSe decreases as the number of samples required to call a herd 
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positive increases.The HSp is based on the assumption that the herd is negative; therefore the 
underlying TP does not affect the HSp, however, HSp increases as the number of tests required 
to call a herd positive increases.For the following sample sizes: 10, 15, 20, and 25; the HSp was 
.98, .97, .99, and .99, respectively (Figure 6.1). 
The HPV+ and HPV- (Figure 6.2) depend on both true within herd prevalence of elevated 
BHBA and the between herd-level prevalence of infected herds, i.e., the pre-test probability of a 
herd being positive.HPV+ increases as the elevated BHBA prevalence within herd and between 
herds increase.Although HPV+ generally increases as sample size increases, there is a notable 
drop when the sample size is 15.The HPV- increases as the within herd true prevalence 
increases, but there is a slight decrease as the prevalence of positive herds increases and there is a 
notable increase when the sample size is 15. 
Figure 6.3 demonstrates the effect of changing test sensitivity and test specificity on HSe 
and HSp, and Figure 6.4 demonstrates the effect of these changes on HPV+ and HPV-.Although 
the herd-level parameters are different, the patterns seen previously when the test sensitivity was 
0.96 and test specificity was 0.98 are similar.   
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Figure 6.1. Herd-level sensitivity (HSe) and herd-level specificity (HSp) based on different 
sample sizes (10 to 25) and varying true prevalence (0 to 40%) of animals with BHBA 
concentrations ≥12 mg/dL within the herd.The test sensitivity and specificity were held constant 
at: 0.96 and 0.98 respectively. 
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Figure 6.2. Herd-level predictive value positive (HPV+) and herd-level predictive value negative 
(HPV-) based on different sample sizes (10 to 25) and varying within herd true prevalence (TP; 
0.1 to 0.4) of animals with BHBA concentration ≥12 mg/dL and a between herd prevalence (the 
pre-test probability that a herd is positive) ranging from 0.1 to 0.4. 
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Figure 6.3. Herd-level sensitivity (HSe) and herd-level specificity (HSp) varying test sensitivity, 
test specificity and underlying true prevalence (TP 20% or 40%) of BHBA ≥ 12 mg/dL. 
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Figure 6.4. Herd predictive value positive (HPV+) and herd predictive value negative (HPV-), 
comparing true prevalence at 20% and 40% and between herd true prevalence (HTP) at 20% and 
40%, varying test sensitivity and test specificity. 
 
 
DISCUSSION 
Pooled samples 
A McNemar’s p-value < 0.05 can indicate that there is serious bias between the two tests 
(Dohoo et al., 2003b); however this bias is usually related to subjective interpretation between 
observers.In the current study, subjective interpretation is not a factor because both tests were 
based on objective laboratory measures, thus a low McNemar’s p-value indicates that the tests 
were different. 
The magnitude of the Kappa value is influenced by the extent of agreement between the 
two tests, the prevalence of the condition being tested, and bias between subjective observers 
(Byrt et al., 1993). Despite the differences in the proportion of positive herds between the 
individual and pooled tests, i.e. prevalence, the Kappa statistic can still be interpreted under the 
HPV- with TP =0.2, HTP = 0.2 
HPV- with TP =0.4, HTP = 0.4 
HPV+ with TP =0.2, HTP = 0.2 
HPV+ with TP =0.4, HTP = 0.4 
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commonly cited scale (Landis and Koch, 1977).Based on this scale, the tests a Kappa value of 
0.13 shows only slight agreement.  
The wide confidence intervals for specificity of the pooled test indicate uncertainty about 
the estimate of specificity and additional herds would need to be tested to improve the accuracy 
of this estimate.It is plausible that an individual cow, with a very high BHBA concentration 
could increase the mean of the pooled test above the metabolite threshold, producing a false 
positive result for excessive NEB.This did not occur in this study because only clinically healthy 
cows were selected for inclusion in the cohort study and as such, elevated levels of BHBA were 
rare. 
Low test sensitivity can lead to a large number of false negatives which means that herds 
at risk will not be identified and opportunities for improvement may be lost.These lost 
opportunities can be very costly because according to Ospina et al., (2010c), herds above the 
herd alarm level, i.e., when more than 15% of animals tested had BHBA ≥ 12 mg/dL, had a 1.8% 
increase in DAs and CK, 0.8% reduced pregnancy rate, -358 ME 305 milk (kgs) when compared 
to herds below the herd alarm level.Therefore, if the goal of testing is to identify herds at risk and 
capitalize on opportunities, the proportion of animals above the herd alarm level and not the 
pooled concentration should be evaluated.  
Individual tests  
Herd level sensitivity and specificity parameters are similar to individual animal 
parameters, such that a large HSe results in fewer false negatives, and similarly a large HSp 
results in fewer false positives.In this scenario, the critical threshold is based on a proportion of 
the animals sampled, the largest HSe is associated with sampling 15 animals, but the highest 
HSp is associated with sampling a larger sample, 20 to 25 animals.It is at the discretion of the 
user which outcome is most important.If one is looking for opportunities to improve, the test 
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with the highest sensitivity would be ideal because false negatives would be limited.However, if 
the cost of the intervention is prohibitive, a test with higher specificity and fewer false positives 
may be warranted.In either case, it is important to select clinically healthy animals.Sick animals 
will likely have elevated markers of NEB. 
When reviewing the HSe and HSp, keep in mind that these calculations were based on 
the individual test Se and Sp and in this study they were maintained at 0.96 and 0.98, 
respectively. These values are within the range of sensitivity and specificity of the Precision Xtra 
meter (Abott Laboratories, Abott Park, Il).The Precision Xtra meter is a handheld device used to 
test blood BHBA concentrations; sensitivity and specificity compared to serum BHBA 
concentrations determined photometrically are 96% and 98%, respectively, when using a cut-off 
value of ≥ 1.2 mg/dL (Konkol et al., 2009).There are other ketone tests on the market with 
varying degrees of sensitivity and specificity.For example: the Ketostix strip (Bayer Corporation, 
Elkhart, IN) evaluates acetoacetate in urine and when read after 5 seconds and interpreted as a 
“trace” had 90% sensitivity and 86% specificity and when interpreted as a “small” has a 78% 
sensitivity and 96% specificity both relative to serum at ≥ 1.4 mg/dL (Carrier et al., 2004); and 
the Ketotest (Sanwa Kagaku Co. Ltd., Nagoya, Japan) for milk when read at ≥ . .05 mg/dL 
relative to serum at ≥ 1.4 mg/dL has 88% sensitivity and 90% specificity (Carrier et al., 2004).  
Herd-level predictive value tests are the herd-level analogues of the individual tests for 
predictive values, such that the HPV+ is the probability that a positive tests comes from a 
positive herd, the HPV- is the probability that a negative tests comes from a negative herd.Given 
that the critical threshold for calling a herd positive requires that more than 15% of the animals 
sampled have BHBA concentrations ≥ 12 mg/dL, when 15 animals are sampled this requires ≥ 2 
animals to test positive and when 20 animals are sampled, this requires ≥ 3 individual animals to 
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test positive.By increasing the absolute number of animals required to test positive to call the 
herd positive, the HPV+ will increase based on sample size.However, because the test used does 
not have perfect specificity, the more animals tested the lower the HPV- will be due to the 
increased probability of false positives. 
The timing and frequency of sampling are important factors to consider.Although there is 
some diurnal and feeding time variation of BHBA levels, ultimately the goal is to sample clinical 
healthy animals at similar time periods within the farm.Sampling at similar times (before or after 
feeding) will decrease the variation based on this factor.It is important to note that BHBA may 
be elevated prior to feeding, so in order to increase the sensitivity of the test, one might want to 
test prior to feeding. 
The frequency of sampling depends on herd size and the type of information desired.In 
herds with fewer than 300 cows, all cows within the risk period (3 to 14 DIM) should be sampled 
and when the individual test results from a group of 15 to 20 animals have been accumulated, the 
proportion of positive animals can be evaluated.Based on research done by McArt et al., (2011), 
it is recommended that animals be sampled between 3 to 10 DIM.In this study, cows were 
sampled repeatedly up to 17 DIM and the highest incidence of subclinical ketosis (BHBA 
concentration ≥ 12 mg/dL) was seen within 3 to 10 DIM.It is important to note that when the 
sampling window is decreased to 3 to 10 DIM, the underlying TP of SCK may be higher than in 
the Ospina et. al., (2010a) study which evaluated animals between 3 to14 DIM.This may result in 
a necessary increase in the proportion of animals that test positive to determine that a herd is 
above the herd alarm level. 
The frequency of sampling in herds with greater than 300 cows will depend on the 
information desired.This flexibility is due to the fact that given the number of cows in the herd; 
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there will be enough cows in the risk period to sample on as needed basis.When evaluating the 
results at the herd-level, i.e., 15 to 20 samples have already been evaluated, the test can be 
evaluated in series, where one negative herd-level test will result in the conclusion of a negative 
overall test.The consequence of testing in series is that the herd-level specificity increases, but 
the herd-level sensitivity decreases.If the herd-level tests are evaluated in parallel, one single 
positive herd-level test will result in the conclusion of a positive overall herd-level test.The 
consequence of testing in parallel is that the herd-level specificity decreases, but the herd-level 
sensitivity of the test increases.If on-going monitoring is desired, testing in series or parallel 
every 2 to 4 weeks is recommended.Sampling at these time intervals will allow evaluation of a 
new population at risk – a new set of healthy animals 3 to 10 DIM. 
CONCLUSION 
It is normal for dairy cows to have some circulating BHBA; however, there is a threshold 
above which disease, decreased milk production and decreased reproductive efficiency are more 
likely.Research about this threshold at the individual animal is useful; however, because 
management strategies are best implemented at the herd or group level, identifying herds or 
groups at risk would allow for appropriate intervention. Although pooled samples may seem like 
a desirable method to evaluate herd-level status due to lower laboratory cost, pooled samples 
have very low sensitivity when compared to individual samples and result in high levels of false 
negatives.When relying on representative, individual-animal samples to estimate herd-level 
status, it is recommended to sample 15 to 20 animals at risk (3 to 10 DIM) and evaluate the 
proportion of animals with BHBA above the critical threshold.Herds with more than 15% of 
animals sampled with BHBA concentrations ≥ 12 mg/dL may benefit from evaluation of 
transition cow management. 
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CHAPTER SEVEN 
 
 
 
OVERALL CONCLUSIONS AND FUTURE DIRECTIONS 
 
  
The energy management mechanisms in place at the beginning of lactation are beneficial 
because they allow the cow to produce milk despite having to enter a state of NEB.Based on this 
system, it is normal for the cow to experience some level of NEB; however, excessive lipolysis, 
estimated by rising concentrations NEFA and BHBA above critical thresholds are associated 
with problems during the transition period.The ability for the cow to manage this energy 
imbalance will dictate whether there are negative effects associated with the NEB, thus resulting 
in the over-representation of both infectious and metabolic diseases during the early stages of 
lactation.This research explored the association between NEFA and BHBA, as markers of NEB, 
and negative downstream outcomes like disease development, decreased milk production, and 
decreased reproduction. 
Association between elevated NEFA and BHBA concentrations and negative 
downstream outcomes       
 The first major objective of this research was to identify the critical threshold above 
which detrimental health outcomes were most likely in individual animals.The health outcomes 
evaluated were DA, CK, MET, and RP.The use of recently recognized statistical methods with 
commercially available statistical software for estimation of the risk ratio (RR), allowed us to 
estimate the RR given the dichotomous outcome (disease or no disease) and several covariates, 
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such as objective concentrations of pre-partum NEFA 0.3 mEq/L, post-partum NEFA 0.7 mEq/L 
and BHBA 12 mg/dL. 
 Once the association between critical thresholds of NEFA and BHBA and detrimental 
health outcomes were established, the relationship between these thresholds and reproduction 
and milk production were evaluated.In general, this research supported the conclusions of others 
that excessive NEB was detrimental to reproduction and milk production.However at the 
individual animal level, primiparous animals behaved differently, milk production was higher in 
animals with elevated post-partum NEFA and BHBA.Although this warrants further 
investigation, the difference in response between cows and heifers may be related to additional 
metabolic demands that a heifer has to balance – skeletal growth and lactation providing an 
additional demand for the excessive energy mobilized from adipose tissue.  
 Although these associations at the individual animal level are important, most farm 
management systems implement changes at the group or herd-level, thus defining an objective 
herd-alarm level was essential.The herd-alarm-level is defined by two numbers: 1) the proportion 
of sampled animals with NEFA or BHBA concentrations above the critical concentration 
threshold, and 2) the critical concentration thresholds that were associated with increased disease 
incidence and decreased reproductive and milk production performance. 
Generally, herds that had more than 15% of the animals tested with pre-partum NEFA > 
0.3 mEq/L, post-partum NEFA > 0.7 mEq/L, or BHBA > 12 mg/dL, had higher disease 
incidence, produced less milk, and had a lower pregnancy rate when compared to herds that had 
fewer than 15% of the animals with metabolite concentrations above this range.In addition, at the 
herd-level, heifers did not demonstrate the same association between NEB and milk production 
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as they did at the individual animal level.The theory is that if enough heifers have elevated 
NEFA and BHBA concentrations post-partum, there is a negative effect on milk production.       
 Once information at the herd-level was established, it was also important to evaluate the 
effect of pooling samples on the interpretation of the herd energy status.Contrary to some of the 
positive results associated with pooling samples for detection of infectious diseases, pooling 
samples for evaluation of NEFA and BHBA as predictors of disease, milk production, and 
reproduction resulted in very low sensitivity.The consequence of low sensitivity is a large 
number of false negatives, which leads to missed opportunities of addressing energy balance 
concerns through pooled samples in the transition period.  
Directions for Future Research 
 The association between excessive NEB and negative downstream outcomes was 
reproduced at multiple levels of this investigation and has been confirmed by other research 
groups.Although mobilization of fat reserves is the primary mechanism for meeting the demands 
for energy, objective measures of corporal changes in response to NEB during the transition 
period are lacking. This is largely due to the fact that access to body weight information is not 
readily available from most commercial dairy farms.However, farms which have adapted robot 
technology for milking have an overload of objective information about the weight of the cow 
because cows are weighed every time they are milked (2-4 times per day).Evaluating the 
association between NEB through NEFA and BHBA concentrations, objective measures of body 
weight and back fat thickness (measured through ultrasound) may improve the understanding of 
the relationship between adipose tissue, body weight, BCS, and NEB. 
 In addition to evaluating subcutaneous fat, an objective measure of visceral fat may also 
help improve the understanding of the association between adipose tissue and negative 
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downstream outcomes.There is some evidence that subcutaneous fat may behave differently than 
fat that surrounds the visceral organs, and perhaps it is the changes in the visceral fat that may 
have a stronger association with negative downstream outcomes.The use of ultrasound 
technology may be used to increase precision and accuracy when evaluating the back fat on 
cow.Although validation studies would need to be performed, the fat around the kidney can be 
measured through rectal ultrasound and may help minimize the knowledge gap between what 
can be seen on the outside and what is going on internally, especially in the cows that do not 
have excessive body condition subcutaneously. 
 Lastly, through collaboration with other researchers, two promising areas of research are 
being investigated.These areas are: the evaluation of decreased metabolite concentrations (when 
they should be elevated) and the ratio between NEFA and BHBA.Unpublished work on the 
association between low BHBA concentrations prior to surgical correction of a DA, showed that 
cows with BHBA concentrations ≤ 12 mg/dL were more likely to die or be culled after 
surgery.This brings up an interesting concept of the exhaustion of energy management 
mechanisms and warrants further investigation.Following this same logic, the evaluation of the 
ratio of NEFA to BHBA and the association of this with negative downstream outcomes may 
improve the understanding of the energy management mechanisms.Although evaluation of this 
ratio is the next step, my hypothesis for the worst case scenario, i.e., increased risk of negative 
downstream outcomes, is: high NEFA and low BHBA.This means that ketones are not being 
produced despite available NEFA, signaling a break down or exhaustion of energy management 
mechanisms, thus higher risk of hepatic lipidosis and subsequent detrimental immune, 
reproductive and milk production outcomes.  
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Final Remarks 
 Science is the pursuit of the truth.The results presented in this dissertation provide 
another level which can be used for understanding the real association between energy balance 
and negative downstream outcomes during the transition period; with the goal of identifying 
animals or herds at risk and to use this information to minimize the risk of disease, improve milk 
production and reproduction.Lastly, based on the wisdom of my advisor, Daryl Nydam, who 
frequently quotes George Box, and says that “although all models are wrong, some models are 
useful”, I hope the information gained from this research should help advance the understanding 
of NEB during the transition period.   
 
 
  
 
 
 
 
